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 Anaplasma phagocytophilum is an obligatory intracellular bacterium that infects 
neutrophils to cause human granulocytic anaplasmosis.  Sialyl Lewis x (sLex)-modified P-
selectin glycoprotein ligand-1 (PSGL-1) is the confirmed receptor utilized by A. 
phagocytophilum to bind and invade human neutrophils and myeloid cell lines.  As an 
obligate intracellular pathogen, the binding of A. phagocytophilum to a host cell receptor is 
a prerequisite step for entry and replication, and thus its survival.  However, the bacterial 
adhesins mediating this process have yet to be identified.  In this study, we sought to 
 
 xvi 
identify surface proteins of A. phagocytophilum as putative adhesins.  A. phagocytophilum 
undergoes a biphasic developmental cycle, transitioning between a smaller electron dense-
cored cell (DC), which has a dense nucleoid, and a larger, pleomorphic electron lucent 
reticulate cell (RC), which has a dispersed nucleoid.  We determined that the respective 
roles of the A. phagocytophilum DCs and RCs are adherence/infection and vacuolar 
replication, respectively, which is a finding that is consistent with the life cycles of other 
obligate intravacuolar pathogens that undergo biphasic development.  Most importantly, 
we demonstrated the A. phagocytophilum DC is responsible for recognizing human PSGL-
1.  To identify surface proteins as putative adhesins we tested a variety of approaches.  
Three different computer prediction programs were compared, resulting in identification of 
16 to 130 potential membrane proteins.  As a more direct means to identify A. 
phagocytophilum surface proteins as PSGL-1 adhesins, several affinity capture approaches 
were tested.  We used commercially available recombinant human PSGL-1 (rhPSGL-1) to 
try and capture adhesins by crosslinking and affinity purification.  We were unsuccessful, 
but nevertheless gained insight into the binding properties of A. phagocytophilum.  We 
next chose to take a broader approach to identify outer membrane proteins of the adherent 
DC by biotinylation.  In the process we developed new density-gradient centrifugation 
approaches which  successfully purified an RC-enriched population as well as a mixed 
population of RC and DC organisms.  Results from this work demonstrate that A. 
phagocytophilum DC organisms are responsible for binding PSGL-1.  Additionally, the 
results obtained thus far of gradient-purified bacteria will serve as a foundation for future 





CHAPTER 1:  Introduction 
 
 
History and Ecology of Anaplasma phagocytophilum  
 The family Anaplasmataceae consists of obligate intracellular bacterial pathogens 
that are distinctive in their ability to replicate in vacuoles within the cytoplasm of a host 
cell.  Located within the order Rickettsiales, five members within the family 
Anaplasmataceae, consisting of Anaplasma phagocytophilum, Ehrlichia chaffeensis, 
Ehrlichia ewingii, Ehrlichia canis and Neorickettsia sennetsu are capable of causing 
disease in humans.  Human infection by these pathogens is generally referred to as 
"ehrlichiosis."  Although members of the family Anaplasmataceae were first recognized as 
early as 1910, reported cases on human ehrlichiosis published from the CDC as a notifiable 
disease has only occurred since 1999 (1, 183).  
 First identified in 1932 as a veterinary agent, the tick-transmitted obligate 
intracellular bacterium A. phagocytophilum has become an increasingly recognized threat 
since 1994, when it was discovered to infect humans (34, 43).  With the support of DNA 
sequencing and genetic analysis of 16S rRNA and groESL genes, three former agents, 
Ehrlichia phagocytophila, Ehrlichia equi and human granulocytic ehrlichiosis (HGE) 
agent that were originally thought unique have since been reclassified in 2001 as the single 
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agent, A. phagocytophilum (42).  A. phagocytophilum infection in humans is now termed 
human granulocytic anaplasmosis (HGA).    
 A. phagocytophilum is transmitted by Ixodes ticks, specifically by I. scapularis in 
the Northeast and upper Midwest United States, I. pacificus in the Western United States, 
I. ricinus in Europe and I. persulcatus in Asia (56, 170).  In the United States, A. 
phagocytophilum is maintained in a transmission cycle between its tick vector and small 
mammals, the primary of which is the white-footed mouse (Peromyscus leucopus) (56, 
169).  Acquisition of A. phagocytophilum by ticks occurs during a blood meal of an 
infected mammalian host, as transovarial transmission does not occur.   Nonetheless, once 
a tick becomes infected transstadial transmission does occur as the tick molts from the 
larva, nymph and to the adult stage (56).  The overall life cycle of Ixodes ticks and 
transmission potential of A. phagocytophilum is outlined in Figure 1A.  Humans are not 
the intended host of ticks, but are susceptible to infection if fed upon by an infected tick.  
Upon tick attachment, transmission of A. phagocytophilum to a murine host can occur 
within 24 hours (40).   
 
Epidemiology  
 The majority of reported HGA cases within the United States occur primarily in 
northern California, the upper Midwest, and the Northeast (119).  This correlation is also 
seen in canines (Fig. 1B) as evidenced by antibodies to A. phagocytophilum (24, 129).  The 
number of HGA cases reported to the CDC was an average of 0.23 cases per 100,000 








Figure 1.  Life cycle of Ixodes ticks and threat of A. phagocytophilum exposure.         
(A) Life cycle of Ixodes species of tick.  Adult females lay uninfected eggs, as transovarial 
transmission does not occur with A. phagocytophilum.  The uninfected larval ticks hatch 
from eggs and acquire their first blood meal.  Once a tick acquires A. phagocytophilum 
from a host, it will remain infected throughout its life cycle as transstadial transmission 
does occur.  Although not the intended host of ticks, humans, canines and other mammals 
can become infected if fed upon by an infected tick.  (B) Potential threat of exposure to A. 
phagocytophilum.  Map indicates by county exposure to A. phagocytophilum as evidenced 
by antibodies detected in canines.  Canines are more frequently exposed to tick bites than 
humans, allowing them to serve as sentinels in determining risk of human exposure and 
infection within particular geographic areas.  Gray shading indicates no results (<10), and 
white indicates no canines reported as positive (0%).  Remaining colors are as follows: 
0.01 - 0.49% (pale green), 0.5 - 1.0% (lichen), 1.1 - 5.0% (kelly green) and 5.1 - 40% (dark 
































much greater as human serological studies in Wisconsin and New York suggest exposure 
is as high as 15% to 36%, respectively (4, 12).  An average of 35 cases per 100,000 people 
was reported over a three-year period in Connecticut, making A. phagocytophilum the 
second most common tick-transmitted pathogen in this state (82).  Serological data clearly 
demonstrates transmission of this pathogen is high; however the occurrence of diagnosed 
disease after exposure is generally less frequent. 
 
Clinical features and treatment 
 Clinical manifestations of HGA range in severity from subclinical or mild infection 
to severe or even fatal disease.  Non-specific symptoms of A. phagocytophilum include 
malaise, fever, myalgia, and headache.  Rarely does rash occur along with infection.  
Laboratory tests typically identify irregularities, which include thrombocytopenia, 
leukopenia, anemia and elevated liver enzymes.  Pathology includes inflammation of the 
liver, slight lymphoid depletion, hyperplasia and hemophagocytosis.  Severe complications 
include prolonged fever, shock, confusion, seizures, pneumonitis, acute renal failure, 
hemorrhages and rhabdomyolysis (41).  Although many infections are asymptomatic and 
may be self-limiting, it is estimated half of all symptomatic individuals require 
hospitalization, with up to 7% admitted to intensive care (10, 43).  HGA has an estimated 
mortality rate of about 1%.  Mortality has occurred from opportunistic infections and the 
severity of disease generally increases with age and immunosuppressed individuals (10).  
 The hallmark of HGA infection is the presence of intravacuolar colonies termed 
morulae, located within the cytoplasm of peripheral granulocytes (149).  The term morulae 
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extends from the punctuate staining of A. phagocytophilum, which looks like mulberries 
when viewed under a light microscope with Giemsa stains (Fig. 2A).  Morulae can be 
detected in blood smears of 25-75% of patients with HGA within the first week of 
infection, although sometimes only 0.1% of neutrophils will be infected (170).  Polymerase 
chain reaction (PCR) also has a high detection rate of 67-90% (44).  If HGA is identified 
or suspected, treatment with doxycycline will usually resolve infection within 1-2 days 
(11, 13).  After treatment, detection of A. phagocytophilum by Giemsa stains and PCR will 
decrease.  Nonetheless, some individuals have reported to display symptoms of fatigue, 
fever and chills 1-3 years after treatment (142). 
 In addition to A. phagocytophilum, the causative agent of Lyme disease - Borrelia 
burgdorferi - is also transmitted by Ixodes spp. ticks.  As a consequence it is not surprising 
that coinfection of ticks and simultaneous transmission of A. phagocytophilum and B. 
burgdorferi to humans can occur (98, 127).  Coinfection contributes to more clinical 
manifestations than those observed with B. burgdorferi or A. phagocytophilum infection by 
themselves (92).  In vitro studies show coinfection results in higher cytokine and 
chemokine production, resulting in impaired barrier functions of human brain 
microvascular endothelial cells (59).  If coinfection is suspected, treatment with 
doxycycline is successful in treating both infections (44). 
 
Intracellular survival and pathogenesis 
 A remarkable characteristic of A. phagocytophilum is its ability to replicate within 










Figure 2.  Examples of A. phagocytophilum morulae in tissue culture cells.  (A) Giemsa 
stain.  Morulae (smaller dark staining purple vacuoles) can be seen within the cytoplasm of 
the host cells.  Within some morulae the punctuate appearance of individual organisms 
(indicated by arrows) can be seen.  (B) Immunofluorescence.  Organisms within morulae 
are detected with antiserum to Msp2(P44), the most abundant surface protein of A. 
phagocytophilum.  Thick and thin dashed lines delineate the host cell and host cell nucleus 
membranes, respectively.  (C) Transmission electron microscopy (8,200x).  Morulae and 
individual organisms are easily distinguished.  Both the electron dense-cored cell (DC) and 
pleomorphic electron lucent reticulate cell (RC) can be distinguished.  All images are of A. 


































survival is largely dependent on neutrophils as their depletion in mice will reduce the 
bacterial load (20).  Infection of mouse neutrophils also results in secretion of the 
chemokine interleukin-8 (IL-8), which promotes additional neutrophils to migrate to sites 
of infection, thereby further promoting A. phagocytophilum survival (5).  It has also been 
more recently demonstrated that A. phagocytophilum can infect human endothelial and 
megakaryocytic cell lines (64, 73).   
 Infection of human neutrophils is linked to its surface expression of platelet selectin 
glycoprotein ligand-1 (PSGL-1), a selectin ligand (58, 74).  The promyelocytic leukemia 
cell line HL-60 expresses PSGL-1 and supports A. phagocytophilum infection (57).  
This cell line represents the standard for in vitro cultivation of A. phagocytophilum.  After 
binding to PSGL-1, A. phagocytophilum enters the cell and resides within a host cell-
derived vacuole.  Within this vacuole A. phagocytophilum will replicate by binary fission.  
The terms morulae, vacuole and inclusion are synonymous with each other.  During 
intracellular development A. phagocytophilum undergoes a biphasic developmental cycle 
consisting of two distinct morphological forms.  These consist of a smaller 
adherent/infectious dense-cored cell (DC) and a larger noninfectious reticulate cell (RC).  
The focus of Chapter 2 is to determine the pathobiological roles of these two forms.  The 
two forms can only be distinguished by transmission electron microscopy (TEM) (Fig. 
2C), as no form specific proteins have been identified to differentiate between RCs and 
DCs by indirect immunofluorescence assay (IFA).  During intracellular replication A. 
phagocytophilum has adapted to utilizing host components for survival, such as acquiring 
host cell amino acids for use, as well as incorporating host cell cholesterol into its 
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membrane (45, 193).  This dependence on the host cell has reduced the genome to 1.47 
Megabases (Mb).   
 To survive within such a hostile intracellular environment, A. phagocytophilum 
utilizes multiple strategies.  Upon entry into human myeloid cells, the A. phagocytophilum 
occupied vacuole recruits Rab GTPases that are associated with recycling endosomes (78).  
Rabs are responsible for organelle identity and regulate endosome maturation.  By 
disguising its self as a recycling endosome, the A. phagocytophilum vacuole prevents its 
maturation to a mature endosome and avoids lysosomal fusion.  This has been further 
demonstrated by exclusion of early endosome markers from the occupied-vacuole, such as 
the transferrin receptor, Rab 5, and early endosome antigen 1 (121).  The A. 
phagocytophilum vacuole also does not acquire Lysosomal-associated membrane protein 1 
(LAMP-1) associated with late endosome and does not acquire vacuole-type H+ ATPases, 
which are required for vacuolar acidification (30, 185). 
 Typically when bacteria are phagocytosed into neutrophils, toxic oxygen 
intermediates are delivered into the phagosome.  This delivery is controlled by the 
assembled nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex on the 
phagosome membrane.  Yet, A. phagocytophilum inhibits transcription of genes encoding 
for components of the NADPH oxidase complex, preventing formation and thus delivery 
of toxic oxygen intermediates into the phagosome (31).  In addition, the ability to scavenge 
exogenous superoxide (O2−) and rapidly detoxify O2− is another strategy A. 
phagocytophilum employs for its survival (28).  
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 The type IV secretion system (T4SS) encoded by A. phagocytophilum is also 
directly responsible for promoting its survival through delivery of bacterial proteins into 
the host cell (150).  Three T4SS proteins have been identified in A. phagocytophilum; 
AnkA, Ats-1 and AptA (101, 132, 165).  AnkA, which contains ankyrin repeats is the best 
studied and characterized of these proteins.  Within minutes of organisms binding to a 
naїve cell and before bacterial entry occurs, AnkA is injected into the cytoplasm of the host 
cell where it is phosphorylated by the Abl-1 tyrosine kinase (81, 101).  After injection, 
AnkA enters the host cell nucleus and modifies gene transcription by directly binding to 
chromatin (54).  Although few bacterial virulence factors have been identified, A. 
phagocytophilum can inhibit host cell apoptosis through multiple pathways (30, 95, 148).  
A. phagocytophilum infection has also been documented to deacetylate histones (52).  
Changes in histone modification presumably have a direct effect on gene expression by 
changing chromatin structure, resulting in compacted chromatin, which limits access to 
transcriptional activation.  All of these effects on the host cell presumably occur to 
promote intracellular survival and allow for increased replication time in neutrophils, as 
peripheral blood neutrophils generally only survive for several days.  
 
Immunopathology 
 During human infection the percentage of infected neutrophils can be exceptionally 
low; nevertheless the pathology can be severe.  This discrepancy between the low level of 
bacteria during infection and high histopathology has always pointed to immune effectors 
as the primary cause of disease.  Cytokines produced during human, mouse, horse and dog 
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infections are similar (97).  The most prominent cytokine produced during infection is 
interferon-γ (IFNγ).  Infection models have demonstrated that IFNγ knockout mice do not 
develop histopathological lesions, regardless of a 5-8 fold increase in the level of 
organisms.  In comparison, when IL-10 knockout mice which lack the ability to repress 
IFNγ production are infected with A. phagocytophilum the bacterial load is identical to a 
wild type control, but the level of histopathology is considerably more severe (110).  This 
demonstrates that histopathologic injury is not directly dependent on the bacterial load, but 
instead depends on host cell immune responses.     
 The immune system pathways that are critical for controlling and eventually 
clearing A. phagocytophilum infections have not been fully elucidated.  When A. 
phagocytophilum is repeatedly passaged in severe combined immunodeficiency (SCID) 
mice, the virulence of A. phagocytophilum can increase and can eventually kill the SCID 
mouse (20).  This suggests that intact immune systems are more beneficial than 
disadvantageous.  In addition, when various components of the innate immune system 
were studied in knockout mice, it was demonstrated that inducible nitric oxide (iNOS), 
phagocyte NADPH oxidase (PHOX), tumor necrosis factor, toll-like receptor (TLR)2, 
TLR4 and myeloid differentiation factor 88 (MyD88) do not contribute to controlling 
infection (182).  Moreover, some of these intact innate immune features during infection 
actually contributed to increased inflammation and hepatic injury (157).  One feature that 
is important for eventual elimination is CD4+ T cells.  But oddly, this clearance occurs in 
the absence of perforin, Fas/FasL and Th1 cytokines such as IL-12 and IFNγ, which are 
effectors generally required for eliminating intracellular pathogens (20).  The unusual 
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feature of A. phagocytophilum to infect neutrophils and its means to avoid pathways that 
successfully eliminates other intracellular pathogens likely points towards an equally 
distinctive and untraditional means required for controlling infection that has yet to be 
fully understood.   
 
Bacterial adhesion-receptor interactions 
 Bacterial adhesins are the "tip of the sword" when it comes to interacting with host 
cell receptors, and are a necessity for the initial steps of colonization and infection.  For 
obligate intracellular pathogens, adhesion and entry into a host cell is more than just an 
arbitrary event, it is a requirement for survival.  Bacterial adhesins are typically classified 
as fimbrial or afimbrial.  Fimbrial adhesins are those that protrude from the surface of 
bacteria, such as various types of pili.  Afimbrial adhesins are those that do not extend 
beyond the organism and are surface bound (90, 139).   
 Bacterial adhesins typically recognize specific structural requirements of their 
respective receptors, which usually restricts the organism to specific tissues or cell types 
(48).  Nevertheless, there are exceptions such as the family of variable outer membrane 
opacity-associated (Opa) proteins of Neisseria that recognize multiple human cell surface 
receptors (181).  Adhesins can bind two types of receptors, protein and carbohydrate (49).  
Carbohydrate moieties can be located on both glycoproteins and glycolipids (39, 49).  The 
respective bacterial adhesins for a given receptor can also be protein or carbohydrate.  In 
fact, the majority of confirmed or suspected bacterial adhesins from many different species 
have been identified as proteinaceous (7, 33, 90, 109, 139, 143, 152, 186, 199).  Even 
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though most adhesins are protein, the importance of bacterial glycosylation and its role in 
adhesion has also been established (18, 37, 53, 75, 176).  Characterization of adhesins is 
crucial to understanding how bacteria initially colonize and infect various cells and tissue, 
and the host cell responses they elicit.  Adhesins are also ideal targets for the development 
of vaccines to prevent infection and colonization by bacteria (35, 93, 94, 191). 
 
A. phagocytophilum adhesins are likely surface exposed proteins 
  Several observations suggest that the A. phagocytophilum adhesin(s) are located 
within the outer membrane and are directly surface exposed.  Foremost, organisms that 
have been incubated with an excess of membrane impermeable crosslinkers (crosslink 
surface proteins), exhibit decreased binding to HL-60 cells, which implies that the 
crosslinkers are either binding to or sterically hindering the adhesin(s) (unpublished data).  
In addition, A. phagocytophilum organisms that have been fixed with paraformaldehyde 
(PFA) still bind specifically to PSGL-1 (194), which demonstrates that the adhesin(s) 
presumably are surface exposed, as fixed organisms could not upregulate or remodel 
protein surface structures.  Also, A. phagocytophilum organisms bind equally well to HL-
60 cells at 4, 23, and 37°C, which demonstrates that binding is not temperature dependent.  
Furthermore, when other obligate intracellular bacterial pathogens that undergo biphasic 
development such as Chlamydia are considered, the infectious form is metabolically inert 
due to compacted chromatin (3).  This would imply the infectious DC form of A. 
phagocytophilum does not possess the ability to upregulate surface proteins in response to 
environmental stimuli.  Indeed, when A. phagocytophilum organisms are isolated from 
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mammalian HL-60 cells and incubated with mammalian and bovine endothelial cell lines, 
they are susceptible to infection (124).  Additionally, we have observed by TEM that the 
infectious DC form of A. phagocytophilum isolated from HL-60 cells binds to mouse mast 
cells (unpublished data).  This strongly implicates the adhesin(s) for multiple cells types 
are likely expressed on the DC surface.   
 To further characterize the nature of the A. phagocytophilum adhesin(s), former 
Carlyon lab member Jonathan Sims extensively tested the binding properties required for 
adhesion to the confirmed human receptor, PSGL-1.  Considering the adhesin-receptor 
interactions discussed in the previous section, organisms were pretreated with enzymes or 
oxidative agents and then tested for their ability to bind PSGL-1.  When organisms were 
treated with lipase to remove lipids, sodium periodate to degrade carbohydrates and 
pronase to degrade proteins, only pretreatment with pronase caused a significant reduction 
in bacterial binding (unpublished data).  These experiments strongly suggest that the 
adhesin(s) is proteinaceous in nature.  Taken as a whole, these experiments and 
observations point to the A. phagocytophilum adhesin(s) as surface exposed proteins.   
 
Major surface protein 2 (Msp2[P44]): The Dominant surface protein 
   Although the surface of A. phagocytophilum acts as a crucial interface for 
adherence to host cells, it has not yet been characterized in depth.  One of the few 
confirmed and most studied surface proteins of A. phagocytophilum is the Msp2(P44) 
family that encode 42- to 49-kilodalton (kDa) transmembrane proteins that carry 
immunodominant B-cell epitopes.  Msp2(P44) proteins share a common structure 
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consisting of a central hypervariable region (HVR) flanked by conserved N- and C-
terminal regions.  The HVRs exhibit strong predictability of being surface exposed, thus 
providing potential sources for surface phenotype diversity (84, 126, 200).  The A. 
phagocytophilum Msp2(P44) proteins are orthologous to those encoded by the Anaplasma 
marginale Msp2 family (134).  A. marginale remains within its ruminant host for the 
animals lifetime, and Msp2 antigenic variation is directly linked to the bacterium's 
persistence in vivo (46, 134).  Likewise, the A. phagocytophilum Msp2(P44) proteins are 
believed to afford antigenic variation (43, 56), and a study that followed the msp2(p44) 
transcriptional profile of a clonal population over the course of equine infection supports 
this hypothesis (105).   
 Diversity in Msp2(P44) results from RecF-mediated gene conversion of a single 
genomic msp2(p44) expression site by partially homologous sequences (14-16, 106, 107).  
The A. phagocytophilum genome contains a large reserve (113 in the sequenced strain, HZ) 
of msp2(p44) genes or gene fragments lacking 5'- or 3'-terminal sequences (45).  The gene 
fragments have been referred to as “functional pseudogenes” (105) because, rather than 
being nonfunctional fragments on their way to elimination, they recombine into the 
msp2(p44) expression site to yield full-length msp2(p44) paralogs (15, 16, 105, 106).  
Proteomic characterization of Msp2(P44) paralogs revealed the protein is 
posttranslationally modified into multiple isoforms and is glycosylated (155, 174).  
Msp2(P44) is also constitutively expressed throughout the developmental cycle (56) and 
can function as a porin (80).   
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 Although some evidence suggests that Msp2(P44) acts as an adhesin (136, 184), 
the data has never been overwhelmingly convincing.  The biggest argument against 
Msp2(P44) functioning as an adhesin is the constant variation of the surface exposed HVR, 
which would have to remain constant to routinely bind the same receptor.  During 
mammalian infection, the immune response to Msp2(P44) is very well conserved and has 
been tested as a suitable antigen for laboratory diagnosis (85, 200).  When mice are 
vaccinated with lysates of purified organisms or passively administered antibodies and 
then challenged by syringe- or tick-transmission, the mice are provided considerable but 
not complete immunity to infection from A. phagocytophilum (166).  The mice that were 
immunized with lysates of purified organisms generate strong antibody responses to 
Msp2(P44).  Given the strong antibody response to Msp2(P44) and the abundance of the 
protein on the surface of A. phagocytophilum, infection should have been largely 
preventable if Msp2(P44) was a true adhesin.  A more probable explanation is antibodies 
to Msp2(P44) coat the surface of the organism and sterically hinder true adhesin(s), thus 
resulting in incomplete protection.    
 
Other surface proteins of A. phagocytophilum 
  The only other study to date that set out to identify additional surface proteins of A. 
phagocytophilum was conducted by Yan Ge and Yasuko Rikihisa (55).  Using a membrane 
impermeable biotin reagent, 14 putative A. phagocytophilum surface proteins were labeled, 
recovered, and identified by mass spectrometry (MS).  Biotinylation has become a 
valuable and reliable technique to identify the cell surface protein composition of many 
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organisms (25, 88, 138, 141, 153).  From this approach, only 2 of the 14 identified proteins 
were further confirmed as surface exposed.  The two newly identified surface proteins are 
designated Asp55 and Asp62.  This study demonstrates biotinylation can serve as a 
reasonable approach to use for identification of A. phagocytophilum surface proteins.   
 Although this study was the first to further characterize the surface of A. 
phagocytophilum, the data from this experiment does have several limitations.  First, both 
a mixture of the adherent/infectious DC and non-adherent/noninfectious RC forms were 
used as the substrate for biotinylation.  Consequently, it cannot be determined whether the 
identified proteins are expressed on only one or both developmental forms.  As we will 
demonstrate in Chapter 2, we believe the adhesin(s) are likely upregulated on the 
adherent/infectious DC form.  Second, recovered biotinylated proteins were resolved by 1 
dimensional sodium dodecyl sulfate - polyacrylamide gel electrophoresis (1D SDS-
PAGE), which yielded many protein bands of interest from which only 7 were chosen for 
analysis.  Since only a select few bands were analyzed, many surface proteins may not 
have been identified.  Third, it has been demonstrated that membrane impermeable biotin 
reagents can gain access through porins to label inner membrane proteins (25).  Some of 
the identified proteins in this study possessed characteristics of integral surface membrane 
proteins, while others did not.  The dominant surface protein of A. phagocytophilum 
Msp2(P44), has been shown to function as a porin (80), which may have potentially 
allowed for labeling and recovery of inner membrane proteins.  In Chapter 5, we use 
biotinylation as a means to identify surface proteins of A. phagocytophilum, but do so 
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using improved methods to address the above limitations and to identify a more 
comprehensive list of surface proteins on the adherent/infectious DC form.   
 
A. phagocytophilum adhesion to sLex-modified PSGL-1 
 As an obligate intracellular pathogen, the binding of A. phagocytophilum to a host 
cell receptor is a prerequisite step for entry and replication, and thus its survival.  However, 
the bacterial adhesin(s) mediating this process have yet to be identified, and therefore 
presents a significant gap in our understanding of A. phagocytophilum pathogenesis.  The 
hallmark characteristic of A. phagocytophilum infection is neutrophil colonization.  It has 
also been documented A. phagocytophilum can infect human bone marrow progenitor cells 
(89).  The uncommon tropism for neutrophils as well as neutrophil precursor cells suggest 
that a specific receptor is targeted by A. phagocytophilum.  The receptor has since been 
identified as platelet selectin glycoprotein ligand-1 (PSGL-1) and the tetrasaccharide sialyl 
Lewis x (sLex), which modifies the PSGL-1 N-terminus (58, 74).  PSGL-1 is highly 
expressed on neutrophils, where its function is to adhere to inflamed endothelial cells 
(117).  Human PSGL-1 is a homodimer consisting of two 120-kDa subunits connected by a 
disulfide bond and is coated with O-glycans (Fig. 3A).  The region critical for A. 
phagocytophilum binding is located on the N-terminal region of PSGL-1.  The 
promyelocytic leukemia cell line HL-60 expresses sLex-modified PSGL-1 and is the 
standard for supporting A. phagocytophilum infection in vitro (57).   
 Three specific determinants are essential for A. phagocytophilum binding.  The 
carbohydrate components include α2,3-linked sialic acid and α1,3-linked fucose of sLex.  
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The protein component is the amino acid sequence YEYLDYDFLPE, which is located in 
the PSGL-1 N-terminus (Fig. 3B) (144, 194).  Antibody blocking or chemical removal of 
any one of these three determinants will significantly reduce A. phagocytophilum binding 
(58, 74, 154, 194).  When sLex and the PSGL-1 N-terminal peptide region are 
independently coupled to a microsphere, A. phagocytophilum binding still occurs.  This 
indicates that sLex does not have to be presented directly on PSGL-1 (194).   
 From this data several adhesin scenarios are proposed for A. phagocytophilum 
adhering to PSGL-1 (Fig. 4).  First, A. phagocytophilum may express one adhesin with 
multiple domains which bind the PSGL-1 N-terminal peptide, fucose, and sialic acid on 
one PSGL-1 molecule (Fig. 4A).  Second, one adhesin with multiple domains could 
simultaneously bind the PSGL-1 N-terminal peptide on one PSGL-1 molecule and fucose 
and sialic acid presented on another glycoprotein (Fig. 4B).  Third,  A. phagocytophilum 
could also express several adhesins each of which individually bind the PSGL-1 N-
terminal peptide, fucose, and sialic acid on one PSGL-1 molecule (Fig. 4C).  Fourth, 
individual adhesins could bind the PSGL-1 N-terminal peptide on one PSGL-1 molecule 
and fucose and sialic acid presented on another glycoprotein (Fig. 4D).  The scenarios in 
which adhesins bind sLex directly presented on PSGL-1 (Fig. 4A and C) are preferred as 
they result in better binding (194).  Higher levels of sLex-modified PSGL-1 expression also 
support better binding (194).   
 Although these scenarios represent basic binding models, A. phagocytophilum 
adhesion could be more complex.  We cannot exclude the possibility a single adhesin as 










Figure 3.  Model of human PSGL-1 and the determinants recognized by A. 
phagocytophilum.  (A) Human PSGL-1 is a homodimer consisting of two 120-kDa 
subunits connected by a disulfide bond.  PSGL-1 is decorated with various serine- and 
threonine-linked oligosaccharides (O-glycans).  The region critical for A. phagocytophilum 
binding is located on the N-terminus of PSGL-1 indicated by the black dashed box.        
(B) Model of the PSGL-1 N-terminal peptide region that is essential for A. 
phagocytophilum binding.  Critical residues include the amino acid region highlighted in 
pink of the peptide backbone, as well as α2,3-sialic acid (blue diamond) and α1,3-fucose 










































Figure 4.  A. phagocytophilum adhesion scenarios.  A. phagocytophilum binding to sLex- 
modified PSGL-1 may occur by several different mechanisms.  (A) A. phagocytophilum 
may express one adhesin with multiple domains that bind the PSGL-1 N-terminal peptide, 
fucose, and sialic acid on one PSGL-1 molecule.  (B) One adhesin could simultaneously 
bind the PSGL-1 N-terminal peptide on one PSGL-1 molecule and fucose and sialic acid 
presented on another glycoprotein.  (C) A. phagocytophilum could express several adhesins 
each of which individually bind the PSGL-1 N-terminal peptide, fucose, and sialic acid on 
one PSGL-1 molecule.  (D) Individual adhesins could bind the PSGL-1 N-terminal peptide 


































of how adhesion occurs, identification of surface proteins as putative adhesin(s) will allow 
greater insight into A. phagocytophilum pathogenesis.  As individuals continue to 
participate in outdoor activities, exposure to this pathogen will continue to increase, 
making the characterization of surface proteins of A. phagocytophilum crucial to 
understanding their role in adhesion, which may serve as potential drug and vaccine targets 
to treat or prevent HGA.   
 
Research objectives 
 As an obligate intracellular pathogen, the binding of A. phagocytophilum to a host 
cell receptor is a prerequisite step for entry and survival.  We know that the susceptibilities 
of human neutrophils and promyelocytic HL-60 cells to A. phagocytophilum are linked to 
bacterial usage of sLex-modified PSGL-1 as the receptor for adhesion and entry.  However, 
the bacterial adhesin(s) mediating this process have yet to be identified.  The overall goal 
and work presented here seeks to identify surface proteins of A. phagocytophilum as 
putative adhesins.  To undertake this objective, we first determined when during A. 
phagocytophilum development the PSGL-1 targeting adhesins are expressed.  We next 
tested several affinity-based approaches to try to capture PSGL-1 adhesin(s).  Lastly, we 







CHAPTER 2:  A. phagocytophilum Dense-Cored Organisms Mediate 





  Sialyl Lewis x (sLex)-modified P-selectin glycoprotein ligand-1 (PSGL-1) 
is the confirmed receptor utilized by A. phagocytophilum to bind and invade human 
neutrophils, bone marrow progenitors, and myeloid cell lines (58, 74).  A. 
phagocytophilum binding to PSGL-1 requires cooperative recognition of the N-terminal 
primary amino acid sequence and the α2,3-linked sialic acid and α1,3-linked fucose of sLex 
(29, 194).  This complex interaction is mediated either by multiple A. phagocytophilum 
adhesins or by a single adhesin having multiple binding domains (29, 194).  The A. 
phagocytophilum adhesin(s) that mediates attachment to human sLex-modified PSGL-1 has 
yet to be identified.   
 A. phagocytophilum undergoes a biphasic developmental cycle, transitioning 
between a smaller electron dense-cored cell (DC), which has a dense nucleoid, and a 
larger, pleomorphic electron lucent reticulate cell (RC), which has a dispersed nucleoid 
(69, 123-125, 140, 151, 185).  The respective pathobiological role that each form plays has 
not been elucidated, but indirect insights into their potential roles are presented when the 
biphasic developmental cycles of other intravacuolar pathogens are considered.  Biphasic 
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development was first identified and is most well studied for Chlamydia species, but it has 
also been observed for two Anaplasmataceae pathogens, Anaplasma marginale (122, 124) 
and Ehrlichia chaffeensis (140, 199), as well as Coxiella burnetii, the causative agent of Q 
fever (70, 116).  Chlamydial elementary bodies (EB), which are analogous to DCs, are 
metabolically inert, environmentally resistant, and mediate attachment to and entry of 
eukaryotic host cells (3).  Following attachment, EBs are internalized via induced 
phagocytosis into a host cell-derived vacuole.  EBs remain within the pathogen-occupied 
vacuole, where they differentiate into noninfectious, metabolically active reticulate bodies 
(RB) and subsequently begin to divide by binary fission.  Next, the progeny RB condense 
into EB and are released to reinitiate infection.  Zhang and colleagues recently 
demonstrated that the E. chaffeensis DCs and RCs play analogous pathobiological roles to 
chlamydial EB and RB, respectively (199).   
 Obligate intracellular pathogen binding to host cells precedes entry and is therefore 
requisite for survival.  An important observation that has been made for both the 
chlamydial EB and E. chaffeensis DC is that they specifically express outer membrane 
proteins that have been identified as adhesin candidates (143, 162, 186, 199), while the RC 
forms of each bacterium do not.  Because A. phagocytophilum also transitions between the 
DC and RC, we hypothesized that adhesins targeting PSGL-1 are expressed on the DC.  To 
test this hypothesis, we monitored A. phagocytophilum development in human 
promyelocytic HL-60 cells over a 72-h time course following synchronous infection and 
tested bacterial populations enriched for DCs or RCs for their abilities to adhere to human 
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PSGL-1 expressed on transfected Chinese hamster ovary (CHO) cell surfaces and to bind 
and infect HL-60 cells.   
 
RESULTS 
A. phagocytophilum binding to, invasion of, and replication within HL-60 cells.   
 To assess which A. phagocytophilum morphological form is responsible for binding 
and invasion of host myeloid cells and to monitor the kinetics of bacterial intracellular 
replication, differentiation between DC and RC, and reinfection, host cell-free A. 
phagocytophilum organisms were added to HL-60 cells.  After removal of unbound 
bacteria, aliquots were processed at different time points over 72 h and observed by 
transmission electron microscopy.  A. phagocytophilum DCs were 0.83 ± 0.24 µm wide, 
had a dense nucleoid and a ruffled outer membrane, and were spheroid (Fig. 5A to H and 
6).  RCs were 0.69 ± 0.36 µm by 1.04 ± 0.44 µm, had dispersed nucleoids and outer 
membranes that were somewhat smoother than those observed for DCs, and were 
pleomorphic.  Representative electron micrographs depicting DCs and RCs are presented 
in Figure 5.  We occasionally observed individual DCs surrounded by a membranous 
projection within inclusions harboring other DCs (Fig. 5A).  A similar observation was 
reported for Ehrlichia species (140). 
 At 40 min and 4 h, only DCs were observed binding to, inducing their uptake by, or 
residing within host cells.  At 40 min, 73.8% (214 of 290) of DCs were bound at the 
surfaces of HL-60 cells or inducing their own uptake by HL-60 cells, while only 26.2% (76 
of 290) had internalized into host cell-derived vacuoles (Fig. 6A to C).  By 4 h, 45.5% (30 
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of 55) had internalized (Fig. 6E and F).  At 40 min and 4 h, internalized DCs were tightly 
associated with the luminal faces of their host cell-derived vacuoles, which were barely 
larger than the DCs themselves (Fig. 6C, E, and F). 
 At 12 h, DCs were no longer associated with host cell surfaces (Fig. 7A).  At this 
time point, the only DCs that were observed were individual bacteria harbored within 
tightly associated vacuoles comparable to those observed at 4 h (data not shown).  The 
majority of pathogen-occupied vacuoles harbored one to a few RCs and were more 
spacious than those harboring DCs.  Thus, bacterial replication had initiated and was 
concomitant with enlargement of the A. phagocytophilum-occupied vacuole.  By 24 h, a 
considerable degree of replication had occurred, as evidenced by large vacuoles containing 
numerous RCs that were more elongated than the RCs observed at 12 h (Fig. 7B).  Some 
vacuoles contained A. phagocytophilum organisms that had begun to condense to DCs 
(Fig. 7B).  By 36 h, multiple inclusions harboring individual DCs or RCs that were tightly 
associated with the luminal walls of their vacuoles were once again observed (Fig. 7C and 
D), which reflects the occurrence of reinfection by A. phagocytophilum organisms that had 
been released between 24 and 36 h.  This premise is further supported by 
immunofluorescent detection of extracellular and HL-60 surface-bound A. 
phagocytophilum organisms at all post-24-h time points (data not shown).  Also at 36 h, 
individual host cells contained mature and nascent A. phagocytophilum inclusions (Fig. 
7D).  Consequently, the infection of the HL-60 culture proceeded asynchronously for the 
remainder of the time course.  This was apparent in cells observed at 48 h and 72 h, at 










Figure 5.  A. phagocytophilum DCs and RCs.  A. phagocytophilum organisms were 
cultivated in HL-60 cells and examined by transmission electron microscopy.  
Representative images of DCs (A to H) and RCs (I to P).  (A to H) DCs were 0.83 ± 0.24 
µm wide, had a dense nucleoid and a ruffled outer membrane, and were spheroid.  The 
arrow in panel A denotes an individual DC surrounded by a membranous projection.  (I to 
P) RCs were 0.69 ± 0.36 µm by 1.04 ± 0.44 µm, had a dispersed nucleoid and an outer 
membrane that was somewhat smoother than that observed for DCs, and were 
pleomorphic.  Panels F and N are magnifications of the boxed areas in panels E and M, 










































Figure 6.  A. phagocytophilum adhesion to, invasion of, and replication within HL-60 
cells.  Host cell-free A. phagocytophilum organisms were incubated with HL-60 cells.  
After 40 min, unbound bacteria were removed and host cells were examined by 
transmission electron microscopy.  (A to C) At 40 min, DC organisms were observed 
binding to and triggering their own uptake by HL-60 cells.  (D to F) At 4 h, some DC 
organisms remained bound at the HL-60 cell surface, while others had been internalized 
into vacuoles that were in close proximity to the host cell surface.  No RC organisms were 
observed interacting with HL-60 cell surfaces.  Scale bars, 0.5 µm.  Representative results 











































Figure 7.  Intracellular development of A. phagocytophilum in HL-60 cells.  Host cell-
free A. phagocytophilum organisms were incubated with HL-60 cells.  After 40 min, 
unbound bacteria were removed and host cells were examined at 12 (A), 24 (B), 36 (C and 
D), 48 (E), and 72 h (F) postinfection by transmission electron microscopy.  Arrowheads 
in panels B and E indicate morulae harboring A. phagocytophilum organisms that are 
transitioning from RCs to DCs.  Arrows in panels D and F denote inclusions that contain 




































numerous DCs or RCs (Fig. 7E and F).  Also observed were inclusions that contained 
bacteria that were transitioning from RCs to DCs (Fig. 7E).  At no time point was fusion of 
morulae observed. 
 Not all A. phagocytophilum organisms that initially bound to HL-60 cell surfaces 
remained attached or successfully entered host cells. At 40 min, 62% of the HL-60 cells 
had attached A. phagocytophilum organisms (data not shown).  By 4 h, the percentage of 
HL-60 cells with bound bacteria had dropped to 29%.  By 24 h, approximately 25% of the 
cells were infected, which suggests that those organisms that had remained bound at 4 h 
successfully invaded. 
 
Quantification of the numbers of A. phagocytophilum organisms observed per morula 
and the relative abundance of DC and RC observed over the course of infection.   
 To better characterize the developmental cycle over the course of infection, the 
numbers of A. phagocytophilum DCs or RCs per morula were counted for each time point.  
The greatest diversity in the number of bacteria per inclusion was observed at 24 h (Fig. 
8A).  At 36 h, the largest numbers of vacuoles containing individual DCs or RCs or two 
RCs were observed, which signified that reinfection had occurred and the newly 
internalized bacteria were transitioning or had recently transitioned into RCs (Fig. 7C and 
D and 8A).  As a prerequisite step for isolating A. phagocytophilum populations enriched 
for DCs or RCs and assessing their differential cellular adherence and recognition of 
PSGL-1, we determined the optimal time points for recovering such bacterial populations 










Figure 8.  Number of A. phagocytophilum organisms observed per morula and the 
relative abundances of DCs and RCs observed over the course of infection.  Values 
presented were determined by enumerating the numbers of A. phagocytophilum organisms 
within individual morulae observed by transmission electron microscopy (A) and the total 
numbers of RCs and DCs in Fig. 6 and 7 (B).  (A) Numbers of organisms observed per 
morula between 12 and 72 h postinfection.  Morulae containing 1 to 2, 3 to 5, 6 to 10, 11 to 
15, and ≥16 organisms were enumerated and are presented as percentages of the total 
number of morulae.  (B) Total numbers of DCs and RCs observed binding to or 



































the time course analysis.  It is important to keep in mind that the true numbers of DCs or 
RCs are underrepresented by this method, as they were determined from two-dimensional 
cross-sections of infected cells.  The greatest relative abundance of RCs with a minimal 
amount of DCs prior to reinfection occurred at 24 h (Fig. 8B).  Though RCs outnumbered 
DCs at all postreplication time points, the greatest number of DCs was observed at 72 h. 
 
DC-enriched A. phagocytophilum organisms bind and infect HL-60 cells more 
effectively than RC-enriched bacteria.   
 Our electron microscopy time course studies revealed that DC, but not RC, 
organisms bound and were internalized into HL-60 cells (Fig. 6 to 8).  We therefore 
rationalized that the A. phagocytophilum DC is more effective than the RC at adhering to 
and invading host cells.  To assess this, we isolated DC- and RC-enriched A. 
phagocytophilum populations from infected HL-60 cells.  Following a synchronous 
infection, host cell-free A. phagocytophilum populations were recovered at 24 and 72 h, 
visualized by electron microscopy, and enumerated.  A. phagocytophilum populations 
isolated at 24 h consisted of 70.1% ± 3.4% RCs and 29.9% ± 3.4% DCs (Table 1).  At 72 
h, 53% more DC organisms were present, as host cell-free bacterial populations contained 
45.8% ± 14.7% DCs.  Accordingly, A. phagocytophilum populations recovered from 
infected HL-60 cells at 24 h and 72 h are denoted as RC- and DC-enriched populations, 
respectively.  Next, comparable amounts of DC- and RC-enriched A. phagocytophilum 
organisms were isolated and incubated with naïve HL-60 cells.  After the removal of 































Figure 9.  Binding and infection of RC- and DC-enriched A. phagocytophilum 
organisms in HL-60 cells.  Comparable amounts of host cell-free A. phagocytophilum 
organisms were isolated at 24 h (RC-enriched) or 72 h (DC-enriched) following a 
synchronous infection and incubated with naïve HL-60 cells for 40 min.  (A) After 
removal of unbound bacteria, aliquots were examined by indirect immunofluorescence 
microscopy and the mean numbers of bound A. phagocytophilum organisms per cell were 
enumerated.  (B) The remainders of each infected HL-60 culture were grown for 96 h, 
during which aliquots were removed at 24-h intervals and assessed for infection, as 
determined by light microscopic detection of morulae.  Results shown are the means of 


































Significantly more DC-enriched organisms bound to HL-60 cells than RC-enriched 
bacteria (Fig. 9A).  Likewise, significantly more morulae were observed at 72 and 96 h 
postinfection within HL-60 cells that had been incubated with DC-enriched bacteria than 
cells that had been incubated with RC-enriched organisms (Fig. 9B). 
 
A. phagocytophilum DC-enriched organisms more effectively bind PSGL-1 CHO cells 
than RC-enriched organisms.   
 Because significantly more binding to and infection of HL-60 cells were observed 
for DC-enriched A. phagocytophilum organisms than RC- enriched bacteria and because 
susceptibility of human neutrophils and HL-60 cells to A. phagocytophilum binding and 
infection is directly attributable to surface expression of PSGL-1 (58, 74, 144), we next 
compared the abilities of comparable amounts of DC- and RC-enriched organisms to bind 
to the surfaces of PSGL-1 CHO cells (100, 192).  In addition to PSGL-1, these cells 
coexpress α1,3-fucosyltransferase VII and core 2 β1,6-N-acetylgluocsaminyltransferase, 
which are required to glycosylate PSGL-1 such that it is decorated with sLex, binds to P-
selectin, and supports A. phagocytophilum binding (29, 74, 100, 194).  Flow cytometry 
analyses confirmed that PSGL-1 CHO cells express PSGL-1 and sLex on their cell surfaces 
(Fig. 10A and B).  Significantly more DC-enriched A. phagocytophilum organisms than 
RC-enriched bacteria bound to PSGL-1 CHO cells in the presence of isotype control 
antibody (Fig. 11).  Monoclonal antibody (MAb) KPL1, which interferes with A. 












Figure 10.  Analysis of PSGL-1 CHO and CHO (‒) cells for PSGL-1 and sLex 
expression.  PSGL-1 CHO and CHO (‒) cells were incubated with anti-PSGL-1 MAb 
KPL-1 (A), anti-sLex MAb CSLEX1 (B), or isotype-matched controls.  Alexa Fluor 488-
conjugated secondary antibodies detected bound primary antibodies.  Representative 












































Figure 11.  Binding of RC- and DC-enriched A. phagocytophilum organisms to  
PSGL-1 CHO and CHO (‒) cells.  Comparable amounts of host cell-free A. 
phagocytophilum organisms isolated at 24 h (RC-enriched) and 72 h (DC-enriched) post-
synchronous infection were incubated with PSGL-1 CHO cells in the presence of anti-
PSGL-1 MAb KPL-1 or isotype control or with CHO (‒) cells.  After removal of unbound 
bacteria, A. phagocytophilum binding was assessed by indirect immunofluorescence 
microscopy.  Representative results of one of three separate experiments are shown.  



































(74, 144, 145, 160), reduced binding by DC- and RC-enriched populations to PSGL-1 
CHO cells to the background binding levels observed for CHO (‒) cells. 
 
Confirmation that the A. phagocytophilum DC specifically recognizes PSGL-1. 
 Because DC-enriched organisms bound most effectively to HL-60 cells and PSGL-
1 CHO cells relative to RC-enriched bacteria (Fig. 9 and 11), we hypothesized that the A. 
phagocytophilum DC specifically recognizes PSGL-1 while the RC does not.  Because 
RC-enriched bacteria more effectively bound to PSGL-1 CHO cells than to CHO (‒) cells 
in the presence of isotype control antibody (Fig. 11), we further hypothesized that the 
contaminating DC in the RC-enriched population mediated PSGL-1 recognition.  To verify 
this, PSGL-1 CHO cells were incubated with comparable amounts of DC- or RC-enriched 
A. phagocytophilum populations and visualized by transmission electron microscopy.  For 
both populations, ≥91.5% ± 3.5% of the A. phagocytophilum organisms that bound to the 
surfaces of PSGL-1 CHO cells were the DC form (Fig. 12A, B, and D).  The few non-DC 
forms attached to PSGL-1 CHO surfaces did not resemble RCs.  Instead, they resembled 
either bacterial membrane ghosts (Fig. 12C) or what appeared to be transitional forms that 
were intermediate in size relative to DCs and RCs and exhibited outer membranes that 
were more ruffled than the RC, but not as ruffled as the DC (Fig. 12E).  These results 
support that the DC is the A. phagocytophilum morphological form that mediates binding 











Figure 12.  A. phagocytophilum DCs, but not RCs, bind to PSGL-1 CHO cells.  
Comparable amounts of host cell-free DC-enriched or RC-enriched populations were 
incubated with PSGL-1 CHO cells.  After removal of unbound bacteria, the PSGL-1 CHO 
cells were examined by transmission electron microscopy.  (A) Percentage of bound A. 
phagocytophilum organisms that are in either the DC stage or other (membrane ghosts or 
transition) stages that were observed bound to the surfaces of PSGL-1 CHO cells.  One 
hundred PSGL-1 CHO cell-associated A. phagocytophilum organisms were counted per 
population per experiment.  Scale bars, 0.5 µm.  Results shown are the means of two 
separate experiments.  Statistically significant values are indicated (**, P < 0.01; ***, P < 
0.001).  (B to E) Representative transmission electron micrographs showing a DC (B and 
D), a membrane ghost (C), or a putative transition stage organism (E) interacting with the 



































 Our data demonstrate that the A. phagocytophilum DC mediates cellular adhesion, 
recognizes human PSGL-1, and invades human myeloid cells, while the RC does not.  In 
the hundreds of transmission electron micrographs of HL-60 or PSGL-1 CHO cells with 
bound or newly internalized A. phagocytophilum examined, DCs were almost always 
observed interacting with the host cell surfaces or within nascent inclusions.  We never 
observed RCs attached to host cell surfaces or within nascent vacuoles.  Similar 
observations have been reported for A. phagocytophilum and E. chaffeensis interactions 
with ISE6 tick embryonic cells and DH82 histiocytoma cells, respectively (123, 199).  In 
rare instances, we observed membrane ghosts or what appeared to be late-transition stage 
organisms exhibiting characteristics of both DC and RC binding to host cell surfaces.  The 
latter observation is not surprising given that A. phagocytophilum differentiation is a 
continual process and syringe lysis of infected cells would conceivably release DC, RC, 
and transition stage organisms for subsequent incubation with host cells.  The abilities of 
DC and transition stage organisms and the inability of RC to bind to human PSGL-1 
presented on eukaryotic cell surfaces hints that expression and/or posttranslational 
modification of the adhesin(s) requisite for PSGL-1 recognition occurs during A. 
phagocytophilum differentiation from RC to DC.  This expression pattern is analogous to 
that for putative adhesins of other obligate vacuolar pathogens that exhibit biphasic 




 The percentage of HL-60 cells with bound A. phagocytophilum organisms declined 
from 62% at 40 min to 29% at 4 h, which suggests that not all A. phagocytophilum DC or 
late transition stage organisms that initially bind to the host cell surfaces are capable of 
remaining bound.  Also, A. phagocytophilum entry into human myeloid cells in vitro is 
variable and can take hours.  Indeed, we observed that only 26.2% of DCs had entered HL-
60 cells by 40 min, while 73.8% remained surface bound.  By 4 h, 45.5% of the DCs had 
entered.  Using fluoresceinated bacteria, we and others have previously shown that it takes 
up to 4 h for an appreciable number of bound A. phagocytophilum organisms to invade 
HL-60 cells or neutrophils (23, 28, 83).  We surmise that inefficient binding and/or 
invasion is related to suboptimal expression or posttranslational modification of adhesins 
or other virulence factors that are requisite for adhesion and/or entry by bacteria that have 
not yet fully differentiated into infectious DC.  AnkA, a type IV secretion system effector, 
is delivered into HL-60 cells within minutes following A. phagocytophilum binding (81, 
101)  We observed newly internalized DCs remaining tightly associated with the inner face 
of the inclusion membrane during initial postinvasion hours.  This may allow A. 
phagocytophilum to continue to deliver AnkA and/or other type IV effectors into the host 
cell cytosol following entry. 
 HL-60 cells are nonphagocytic (26, 135), yet we observed HL-60 plasma 
membrane extensions engulfing bound organisms, which indicates that cytoskeletal 
rearrangement is evoked upon A. phagocytophilum binding, presumably to PSGL-1.  Our 
visualization of this process is in agreement with published electron micrographs depicting 
A. phagocytophilum invasion of ISE6 cells and E. chaffeensis invasion of DH82 cells (123, 
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199) but contradicts the supposition that the bacterium enters via receptor-mediated 
endocytosis, not phagocytosis (103, 195).  PSGL-1 is a signaling molecule in leukocytes 
(178).  A. phagocytophilum engagement of PSGL-1 activates the tyrosine kinase, Syk, a 
step that is essential for PSGL-1-dependent entry (145, 171, 178).  PSGL-1 is present and 
interacts with Syk in lipid rafts at the myeloid cell surface (2).  PSGL-1 association with 
Syk is mediated through ezrin and moesin (6, 178), which also function as membrane-actin 
cytoskeleton linkers and play roles in the formation of protrusive membrane structures 
such as filopodia and membrane ruffles (87).  Thus, we propose that A. phagocytophilum 
binding of PSGL-1 promotes actin cytoskeletal rearrangement through Syk-ezrin/moesin-
mediated signaling, which culminates in induced phagocytic- rather than endocytic-
bacterial uptake.  Further support for our premise comes from observations that treatment 
with methyl-β cyclodextrin, which disrupts lipid rafts by chelating cholesterol (66), 
prevents Syk recruitment to interact with PSGL-1 (2) and prevents A. phagocytophilum 
entry (103). 
 Our data demonstrate that A. phagocytophilum RCs are the replicative form.  At 4 
h, individual DCs were observed within nascent inclusions.  By 12 h, individual or 
multiple RCs were present within inclusions, thereby signifying that replication had 
initiated.  The A. phagocytophilum genome codes for ftsZ (APH_1292) (96), which 
suggests that replication occurs by binary fission.  By 24 h, the number of RCs within 
morulae had increased considerably.  During this burst of replication, the morula 
membrane increases in size, which partially accommodates the large numbers of RCs it 
harbors.  However, intravacuolar space does become limited.  Indeed, RCs within mature 
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inclusions harboring large bacterial numbers are more elongated than the individual or few 
spheroid RCs within nascent vacuoles, perhaps as a means of conforming to the available 
intravacuolar space. 
 A. phagocytophilum development within HL-60 cells is asynchronous.  By 24 h, 
condensation of RC into DC has initiated within some, but not all, morulae.  After 
replication to a considerable number of RCs within individual morulae, A. 
phagocytophilum organisms condense into DCs and are subsequently released in a timely 
manner to initiate new infections.  This premise is supported by observations that multiple 
vacuoles harboring individual organisms were once again observed at 36 h and that RCs 
outnumbered DCs at all time points after RCs were first observed.  Whether these 
developmental kinetics are reminiscent of the development within neutrophils and whether 
A. phagocytophilum DCs are released from host cells in a lytic or nonlytic fashion remain 
to be confirmed. 
 A. phagocytophilum development within individual morulae within HL-60 cells is 
highly synchronous, an observation that is consistent with that of A. phagocytophilum 
development within ISE6 cells and E. chaffeensis development within DH82 cells (123, 
199).  Interestingly, the chlamydial developmental cycle within inclusions is asynchronous 
(3).  Thus, these two obligate intravacuolar bacterial pathogens, each of which undergoes 
biphasic development, are prompted by distinct signals to transition from DC (or EB) to 
RC (or RB).  It has been proposed that chlamydial RB detachment from the vacuolar face 
of the inclusion membrane caused by overcrowding within the inclusion provides the 
signal for RB to condense to EB (76).  Such a model does not apply to A. 
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phagocytophilum.  Rather, the synchronous development of A. phagocytophilum within 
inclusions suggests that the entire intravacuolar population simultaneously receives signals 
that prompt differentiation.  Also in contrast to what has been observed for Chlamydia 
species (3) is that we never observed fusion between morulae.  Even as HL-60 cells 
became heavily infected, morulae in direct contact with each other remained distinct.  This 
is in agreement with our previous observation that independent morulae containing 
transgenic A. phagocytophilum organisms expressing either green fluorescent protein or 
mCherry within the same HL-60 cell do not fuse (145). 
 A. phagocytophilum organisms isolated at 72 h bind more effectively to and yield 
more productive infections of HL-60 cells than bacteria isolated at 24 h.  This is due to the 
presence of more adherence-competent and infectious DC organisms being present at 72 h 
than at 24 h.  Nevertheless, the mean standard deviations of bound organisms per cell and 
the percentages of infected HL-60 cells were considerably greater for DC-enriched 
populations (Fig. 9).  We attribute this to the fact that at 24 h, the relative amounts of RCs 
and DCs were consistent for each of the three A. phagocytophilum populations isolated and 
used as inocula, while the RC-to-DC ratio varied among the three inoculum populations 
isolated at 72 h (Table 1).  The variability at 72 h is a result of asynchronous development 
occurring later in infection.  The marginal binding of A. phagocytophilum organisms of 
RC-enriched populations to HL-60 and PSGL-1 CHO cells is due to the contaminating 
DC, a premise that is supported by the fact that electron microscopy detected only DC 
binding to PSGL-1 CHO cells following incubation with RC-enriched populations.
 Neoexpression of fucosylated PSGL-1 in CHO cells is an effective model for 
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studying A. phagocytophilum interactions with PSGL-1.  Intriguingly, we never observed 
morulae within PSGL-1 CHO cells even at 24 h postinfection (data not shown).  This is in 
striking contrast to the ability of the bacterium to not only bind but also to enter and 
replicate within B lymphoblastoid BJAB cells transfected to express fucosylated PSGL-1 
(74) and hints that certain host cell factors and/or signaling platforms may be required to 
optimally support A. phagocytophilum. 
 In closing, the respective roles of the A. phagocytophilum DCs and RCs are 
adherence/infection and vacuolar replication, an observation that is consistent with the life 
cycles of other obligate intravacuolar pathogens that undergo biphasic development.  
Moreover, the A. phagocytophilum DC is responsible for recognizing PSGL-1, the 
dominant receptor for infection of human myeloid cells.  Future characterization of the DC 
surface proteome will be vital to identifying the adhesin(s) that mediate PSGL-1 
recognition.  Deciphering the adherence mechanism by which A. phagocytophilum engages 
PSGL-1 as a prerequisite for host cell entry will characterize a vital step in A. 
phagocytophilum pathogenesis and potentially lead to the development of novel, 




Cultivation of A. phagocytophilum and CHO cells.  A. phagocytophilum strains HZ and 
NCH-1 were cultured in HL-60 cells (28).  HZ was a gift from both Ralph Horwitz of New 
York Medical College (Valhalla, NY) and Yasuko Rikihisa of The Ohio State University 
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(Columbus, OH).  Untransfected CHO cells [CHO(‒)] and transfected CHO cells 
coexpressing human PSGL-1, α1,3-fucosyltransferase VII, and core 2 β1,6-N 
acetylglucosaminyltransferase (PSGL-1 CHO) were gifts from Rodger McEver (Oklahoma 
Medical Research Foundation) and were maintained as described previously (100). 
 
Assessment of A. phagocytophilum binding to, invasion of, and intracellular 
development in HL-60 cells by electron microscopy.  Host cell-free A. phagocytophilum 
organisms were recovered from twice the number of infected HL-60 cells and added to 
naïve HL-60 cells to initiate a synchronous infection.  Aliquots (8.0 x 106 cells) were 
removed at 0.7, 4, 12, 24, 36, 48, and 72 h.  The A. phagocytophilum-infected HL-60 cells 
were washed once in 0.1 N Sorenson phosphate buffer (SPB), pH 7.4, to remove any 
media and immediately fixed in 3.5% glutaraldehyde made in 0.1 N SPB for 1 h.  Samples 
were subjected to four 15-min washes in 0.1 N SPB with 4% sucrose and stained with 1% 
OsO4 in 0.1 N SPB for 1 h at 4 degrees Celsius (°C).  Samples were washed five times in 
0.1 N SPB with 4% sucrose for 3 min each, followed by dehydration in a graded series of 
50, 70, 80, 90, and 100% ethanol for 5 min each.  Next, propylene oxide (PO) was used to 
wash each sample twice for 5 min each, after which a 1:1 mixture of PO and LX-112 resin 
mixture was added.  Resin mixture consisted of dodecenyl succinic anhydride, nadic 
methyl anhydride, LX-112 resin, and 2,4,6-tri(dimethylaminomethyl) phenol (Ladd 
Research, Williston, VT).  Samples were left overnight under a heat lamp.  The next day, 
the PO-LX-112 resin mixture was removed and the samples were incubated in LX-112 
resin mixture for 5 h under a heat lamp.  Samples were centrifuged, the resin mixture was 
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removed, fresh resin was added, and samples were allowed to harden at 60°C for 48 h.  
Samples were thin sectioned on a Reichert Jung Ultracut E microtome, poststained with 
uranyl acetate, and examined in a Tecnai BioTWIN 12 (Philips, Hillsboro, OR) or JEM-
1230 (JEOL, Tokyo, Japan) transmission electron microscope. 
 
Preparation of RC- and DC-enriched populations of A. phagocytophilum.  RC- or DC 
enriched populations of A. phagocytophilum organisms were prepared as follows.  Bacteria 
were liberated from infected (≥90%) HL-60 cells by syringe lysis, followed by differential 
centrifugation to separate bacteria from host cell debris (27).  We empirically determined 
that an infection seeded from bacteria obtained from 10 times the number of infected cells 
that proceeds for 24 h yields a bacterial load that is comparable to an infection seeded from 
two times the number of infected cells that proceeds for 72 h.  Accordingly, host cell-free 
bacteria obtained from 10 or 2 times the number of infected cells were added to uninfected 
cells to establish synchronous infections that proceeded for 24 or 72 h, respectively.  To 
allow for bacterial adherence, A. phagocytophilum organisms were incubated with 2.0 x 
106 HL-60 cells in 1 milliliter (ml) of Iscove’s modified Dulbecco’s Eagle medium 
(IMDM) (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS) 
(IMDM-10).  Host cells were sedimented at 300 x g for 5 min, washed twice with 
phosphate-buffered saline (PBS) to remove unbound bacteria, and incubated at 37°C in 5% 
carbon dioxide (CO2).  To quantify the percentages of A. phagocytophilum host cell-free 
RC- and DC-enriched organisms at 24 and 72 h, respectively, the infected host cells were 
syringe lysed and the bacteria were recovered by differential centrifugation and processed 
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for electron microscopy as described above.  Multiple sections for each sample were 
viewed, and several hundreds to thousands of individual RCs and DCs were counted. 
 
Assessment of binding to and infection of HL-60 cells by RC- and DC-enriched 
populations of A. phagocytophilum using immunofluorescence microscopy and light 
microscopy.  DC- or RC-enriched populations of A. phagocytophilum organisms were 
prepared as described above.  At 24 or 72 h, RC- or DC-enriched A. phagocytophilum 
populations, respectively, were recovered from two times the number of infected cells and 
added to naïve HL-60 cells to establish a second synchronous infection, which was 
assessed for bacterial binding by immunofluorescence microscopy.  Samples were 
monitored for infection by using light microscopic examination of samples that had been 
centrifuged onto glass slides using a Shandon Cytospin 4 cytocentrifuge (Thermo 
Scientific, Waltham, MA) at 24, 48, 72, and 96 h postinfection as described previously 
(27). 
 
Measurement of PSGL-1 and sLex expression of CHO cells by flow cytometry.  CHO 
cells were removed from adherent flasks with 0.5 millimolar (mM) 
ethylenediaminetetraacetic acid (EDTA) (Irvine Scientific, Santa Ana, CA).  Cells were 
treated with Fc block (5µg/ml) (BD Pharmingen, San Diego, CA) for 5 min, followed by 
incubation with CSLEX (binds to sLex) (BD Pharmingen) (51), KPL1 (binds to the human 
PSGL-1 N terminus) (BD Pharmingen) (160), or murine immunoglobulin G1 (IgG1) or 
murine IgM isotype control antibodies (5 µg/ml).  Following 30 min on ice, the cells were 
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washed twice with PBS.  Alexa Fluor 488-conjugated goat secondary antibody against 
either mouse IgM or IgG (Invitrogen) was added to a final concentration of 5 µg/ml.  After 
30 min on ice, the cells were washed with PBS, fixed with 1% PFA, and analyzed on a BD 
Biosciences FACScan using CellQuest Pro software (BD Pharmingen). 
 
Assessment of A. phagocytophilum binding to CHO cells by immunofluorescence 
microscopy.  PSGL-1 CHO or CHO (‒) cells were grown on 12-mm diameter round 
coverslips (Electron Microscopy Sciences, Hatfield, PA) in 24-well tissue culture plates 
(Greiner Bio-One, Monroe, NC) to near-confluent monolayers.  The cells were washed 
twice with PBS.  PSGL-1 CHO cells were pretreated with KPL-1 or mouse IgG1 at 10 
µg/ml for 30 min on ice.  Next, comparable amounts of RC-enriched (isolated 24 h post-
synchronous infection as described above) or DC-enriched (isolated 72 h post-synchronous 
infection) A. phagocytophilum organisms were added at an approximate ratio, using host 
cell-free organisms liberated from twice the number of infected HL-60 cells as naïve CHO 
cells.  Following a 30-min incubation at 25°C with rocking, the cells were washed three 
times with PBS to remove unbound organisms.  Cells were fixed with methanol, and 
bound organisms were detected by immunofluorescence microscopy and enumerated (27). 
 
Assessment of binding of DC- or RC-enriched A. phagocytophilum organisms to CHO 
cells using electron microscopy.  Comparable amounts of DC- or RC-enriched host cell-
free bacterial populations were liberated from 10 times the number of infected HL-60 cells 
and added to naïve CHO cells.  Bacteria and CHO cells were incubated at a concentration 
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of 2.0 x 106 CHO cells in 1 ml of PBS for 30 min at 25°C.  The cells were centrifuged at 
300 x g and washed twice with PBS to remove unbound bacteria and processed for 
electron microscopy as described above. 
 
Statistical analyses.  Student’s (paired) t test performed using the Prism 4.0 software 
package (GraphPad, San Diego, CA) was used to assess statistical significance.  Statistical 







CHAPTER 3:  In Silico Identification of A. phagocytophilum              




 Having established that the A. phagocytophilum DC is responsible for binding 
human sLex-modified PSGL-1 and the adhesin(s) are likely surface exposed proteins, the 
next approach was to predict how many outer membrane proteins (OMPs) may be 
encoded.  In 2006, the complete genome of A. phagocytophilum (strain HZ) was sequenced 
and annotated (45).  Sequence analysis identified several important observations about 
membrane structure.  It revealed that, although classified as a gram-negative organism by 
gram stain, A. phagocytophilum has lost all genes for Lipid A synthesis and lacks most of 
the genes for peptidoglycan synthesis (45, 102).  As a means to potentially compensate for 
the loss of Lipid A, host cell cholesterol is inserted in the membrane (193).  Sequence 
analysis also noted A. phagocytophilum does not encode any pili or capsules (45), so all 
OMPs are most likely afimbrial integral membrane proteins. 
  To generate a list of putative surface proteins, we sought to analyze the A. 
phagocytophilum genome by computer programs.  There are a variety of prediction 
programs available and some even claim to have a lower error of prediction rate than 
experimental laboratory approaches (147).  To obtain an approximate number of how 
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many A. phagocytophilum OMPs may be encoded, we compared 2 computer prediction 
program results to those predicted when the genome was sequenced.   
 
RESULTS 
TIGR predicted OMPs.   
 The Institute of Genomic Research (TIGR) sequenced A. phagocytophilum (strain 
HZ) (45), which was annotated and divided into 25 gene role categories.  A total of 43 cell 
envelope proteins were predicted by TIGR and is listed in Table 2.  Due to the large 
number of Msp2(P44) paralogs and its known surface localization, it was excluded from 
all computer analysis.  
 
CELLO and PSORTb predicted OMPs.   
 The A. phagocytophilum genome was analyzed by the subCELlular LOcalization 
predictor program (CELLO) (196)  and PSORTb (197) to predict potential OMPs.  CELLO 
confidently identified 65 OMPs as well as 65 proteins that could localize to the outer 
membrane and elsewhere.  In total, CELLO predicted up to 130 proteins that could 
potentially function as OMPs (Table 3).  PSORTb was more conservative in analysis as it 
only predicted 16 OMPs (Table 4).   
 
DISCUSSION 
 When results of the different computer prediction programs were compared, the 





Table 2.  TIGR predicted Ap OMPs 
 Ap protein 
Predicted Cellular 
Location 
1 APH_0094 Outer Membrane 
2 APH_0221 Outer Membrane 
3 APH_0234 Outer Membrane 
4 APH_0338 Outer Membrane 
5 APH_0382 Outer Membrane 
6 APH_0383 Outer Membrane 
7 APH_0385 Outer Membrane 
8 APH_0386 Outer Membrane 
9 APH_0387 Outer Membrane 
10 APH_0449 Outer Membrane 
11 APH_0452 Outer Membrane 
12 APH_0453 Outer Membrane 
13 APH_0454 Outer Membrane 
14 APH_0455 Outer Membrane 
15 APH_0457 Outer Membrane 
16 APH_0510 Outer Membrane 
17 APH_0540 Outer Membrane 
18 APH_0541 Outer Membrane 
19 APH_0594 Outer Membrane 
20 APH_0611 Outer Membrane 
21 APH_0612 Outer Membrane 
22 APH_0625 Outer Membrane 
23 APH_0728 Outer Membrane 
24 APH_0878 Outer Membrane 
25 APH_0919 Outer Membrane 
26 APH_0922 Outer Membrane 
27 APH_0924 Outer Membrane 
28 APH_0949 Outer Membrane 
29 APH_0985 Outer Membrane 
30 APH_0995 Outer Membrane 
31 APH_1017 Outer Membrane 
32 APH_1049 Outer Membrane 
33 APH_1210 Outer Membrane 
34 APH_1219 Outer Membrane 
35 APH_1220 Outer Membrane 
36 APH_1240 Outer Membrane 
37 APH_1250 Outer Membrane 
38 APH_1325 Outer Membrane 
39 APH_1345 Outer Membrane 
40 APH_1358 Outer Membrane 
41 APH_1359 Outer Membrane 
42 APH_1361 Outer Membrane 
43 APH_1387 Outer Membrane 
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Table 3.  CELLO predicted Ap OMPs 
 Ap protein Predicted Cellular Location 
1 APH_0015 Outer 
2 APH_0018 Outer 
3 APH_0023 Outer 
4 APH_0035 Outer 
5 APH_0043 Outer 
6 APH_0050 Outer 
7 APH_0051 Outer 
8 APH_0068 Outer 
9 APH_0081 Outer 
10 APH_0110 Outer 
11 APH_0117 Outer 
12 APH_0221 Outer 
13 APH_0328 Outer 
14 APH_0376 Outer 
15 APH_0392 Outer 
16 APH_0404 Outer 
17 APH_0405 Outer 
18 APH_0406 Outer 
19 APH_0469 Outer 
20 APH_0506 Outer 
21 APH_0537 Outer 
22 APH_0582 Outer 
23 APH_0597 Outer 
24 APH_0614 Outer 
25 APH_0634 Outer 
26 APH_0683 Outer 
27 APH_0705 Outer 
28 APH_0707 Outer 
29 APH_0708 Outer 
30 APH_0716 Outer 
31 APH_0723 Outer 
32 APH_0755 Outer 
33 APH_0805 Outer 
34 APH_0807 Outer 
35 APH_0808 Outer 
36 APH_0811 Outer 
37 APH_0838 Outer 
38 APH_0839 Outer 
39 APH_0849 Outer 
40 APH_0861 Outer 
41 APH_0874 Outer 
42 APH_0905 Outer 
43 APH_0906 Outer 
44 APH_0976 Outer 
45 APH_1013 Outer 
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46 APH_1014 Outer 
47 APH_1037 Outer 
48 APH_1050 Outer 
49 APH_1069 Outer 
50 APH_1117 Outer 
51 APH_1127 Outer 
52 APH_1153 Outer 
53 APH_1170 Outer 
54 APH_1210 Outer 
55 APH_1219 Outer 
56 APH_1220 Outer 
57 APH_1240 Outer 
58 APH_1310 Outer 
59 APH_1348 Outer 
60 APH_1358 Outer 
61 APH_1359 Outer 
62 APH_1361 Outer 
63 APH_1378 Outer 
64 APH_1404 Outer 
65 APH_1406 Outer 
66 APH_0112 Outer / Cytoplasmic 
67 APH_0331 Outer / Cytoplasmic 
68 APH_0377 Outer / Cytoplasmic 
69 APH_0385 Outer / Cytoplasmic 
70 APH_0390 Outer / Cytoplasmic 
71 APH_0420 Outer / Cytoplasmic 
72 APH_0421 Outer / Cytoplasmic 
73 APH_0465 Outer / Cytoplasmic 
74 APH_0503 Outer / Cytoplasmic 
75 APH_0504 Outer / Cytoplasmic 
76 APH_0625 Outer / Cytoplasmic 
77 APH_0673 Outer / Cytoplasmic 
78 APH_0761 Outer / Cytoplasmic 
79 APH_0832 Outer / Cytoplasmic 
80 APH_0847 Outer / Cytoplasmic 
81 APH_0852 Outer / Cytoplasmic 
82 APH_0897 Outer / Cytoplasmic 
83 APH_0928 Outer / Cytoplasmic 
84 APH_0933 Outer / Cytoplasmic 
85 APH_0997 Outer / Cytoplasmic 
86 APH_1148 Outer / Cytoplasmic 
87 APH_1158 Outer / Cytoplasmic 
88 APH_1233 Outer / Cytoplasmic 
89 APH_1270 Outer / Cytoplasmic 
90 APH_1303 Outer / Cytoplasmic 
91 APH_1320 Outer / Cytoplasmic 
92 APH_1322 Outer / Cytoplasmic 
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93 APH_1325 Outer / Cytoplasmic 
94 APH_1346 Outer / Cytoplasmic 
95 APH_0314 Outer / Cytoplasmic / Extracellular 
96 APH_0514 Outer / Cytoplasmic / Extracellular 
97 APH_0709 Outer / Cytoplasmic / Extracellular 
98 APH_0829 Outer / Cytoplasmic / Extracellular 
99 APH_0876 Outer / Cytoplasmic / Extracellular 
100 APH_1120 Outer / Cytoplasmic / Extracellular 
101 APH_0473 Outer / Cytoplasmic / Extracellular / Periplasmic 
102 APH_0198 Outer / Cytoplasmic / Inner 
103 APH_0916 Outer / Cytoplasmic / Inner 
104 APH_0944 Outer / Cytoplasmic / Inner 
105 APH_1110 Outer / Cytoplasmic / Inner 
106 APH_0045 Outer / Cytoplasmic / Periplasmic 
107 APH_0104 Outer / Cytoplasmic / Periplasmic  
108 APH_0311 Outer / Cytoplasmic / Periplasmic 
109 APH_0985 Outer / Cytoplasmic / Periplasmic  
110 APH_1049 Outer / Cytoplasmic / Periplasmic 
111 APH_1107 Outer / Cytoplasmic / Periplasmic  
112 APH_1246 Outer / Cytoplasmic / Periplasmic 
113 APH_1412 Outer / Cytoplasmic / Periplasmic 
114 APH_0032 Outer / Extracellular 
115 APH_0049 Outer / Extracellular 
116 APH_0378 Outer / Extracellular 
117 APH_0387 Outer / Extracellular 
118 APH_0546 Outer / Extracellular 
119 APH_0688 Outer / Extracellular 
120 APH_0941 Outer / Extracellular 
121 APH_0206 Outer / Inner 
122 APH_0256 Outer / Inner 
123 APH_0386 Outer / Inner 
124 APH_0430 Outer / Inner 
125 APH_0918 Outer / Inner 
126 APH_0740 Outer / Periplasmic 
127 APH_1015 Outer / Periplasmic 
128 APH_1090 Outer / Periplasmic 
129 APH_1150 Outer / Periplasmic 
130 APH_1384 Outer / Periplasmic 













Table 4.  PSORTb predicted Ap OMPs 
 Ap protein  
Predicted Cellular 
Location 
1 APH_0043 Outer Membrane 
2 APH_0068 Outer Membrane 
3 APH_0338 Outer Membrane 
4 APH_0377 Outer Membrane 
5 APH_0404 Outer Membrane 
6 APH_0405 Outer Membrane 
7 APH_0406 Outer Membrane 
8 APH_0506 Outer Membrane 
9 APH_0709 Outer Membrane 
10 APH_0906 Outer Membrane 
11 APH_1087 Outer Membrane 
12 APH_1110 Outer Membrane 
13 APH_1210 Outer Membrane 
14 APH_1240 Outer Membrane 
15 APH_1359 Outer Membrane 










comparing the TIGR predicted OMPs to those of CELLO, only 15 proteins were shared.  
They were APH_0221, 0385, 0386, 0387, 0625, 0985, 1049, 1210, 1219, 1220, 1240, 
1325, 1358, 1359 and 1361.  Only 5 of the TIGR proteins (APH_0338, 1210, 1240, 1359 
and 1361) were identified by PSORTb.  A total of 4 proteins (APH_1210, 1240, 1359 and 
1361) were identified by all 3 computer programs.  All but 2 proteins (APH_0338 and 
1087) identified by PSORTb were also identified by CELLO, indicating PSORTb is 
stricter in its predictions.  CELLO and PSORTb, but not TIGR was able to predict the 
confirmed surface proteins APH_0405 (Asp55) and APH_0404 (Asp62).  All programs 
also predicted the dominant OMP, Msp2(P44) (data not shown). 
 The validity of the computer programs is partially validated by the Yan Ge and 
Yasuko Rikihisa's surface biotinylation study of A. phagocytophilum (55).  They identified 
14 proteins, 7 of which were predicted by the computer programs.  Three proteins 
(APH_1210, 1359 and Msp2[P44]) were predicted by all 3 computer programs.  The two 
confirmed OMPs (APH_0405 [Asp55] and 0404 [Asp62]) were predicted by CELLO and 
PSORTb.  The final two proteins (APH_1170 and 1406) were only predicted by CELLO.  
This is reminiscent of a study of Helicobacter pylori in which biotinylation  experimentally 
identified 18 OMPs, and only 2 were predicted as surface proteins (153).   
 One limitation of prediction programs for our purposes is that it still does not 
determine whether or not the OMP is specifically expressed on the DC, RC or both 
developmental forms.  As demonstrated in Chapter 2, the adhesin(s) are upregulated or 
posttranslationally modified on the adherent/infectious DC form.  Therefore, our goal is to 
only pursue OMPs on the DC.  A further concern is that other organisms, such as 
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Chlamydia, that also lack peptidoglycan and undergo biphasic development, stabilize the 
infectious EB's outer membrane by forming numerous disulfide bonds with two cysteine-
rich proteins (47, 67).  This results in the environmentally resistant and stable infectious 
Chlamydial EB that can survive harsh treatments with detergents and even sonication, 
whereas the fragile non-cross-linked chlamydial replicative RB is destroyed by these 
treatments (68, 156, 167).  The two cysteine-rich proteins responsible for stability are 
believed to be located in the inner leaflet of the outer membrane and periplasmic space.  
Their inter- and intra-molecular bonds has made their solubility properties variable, 
depending on the treatment used for isolation (47), representing the overall complexity and 
unusualness of the Chlamydial membrane.  A. phagocytophilum likely uses a similar 
strategy for stability as the infectious DC form can remain structurally intact even after 
several minutes of sonication.  This property of the infectious A. phagocytophilum DC is 
discussed in further detail in Chapter 5.  Although unknown at this time, if A. 
phagocytophilum also were to stabilize the DC by disulfide bonds or other unknown 
mechanisms, it could potentially stabilize proteins in the outer membrane that do not 
possess typical membrane features.  If this were true, computer prediction programs may 
not identify such proteins as they typically classify proteins based on structural features.  
 Although computer predictions can serve as a valuable resource, their use in 
predicting OMPs of A. phagocytophilum may be limiting.  The inconsistency of prediction 
between programs, the uniqueness of the membrane (lack of Lipid A and peptidoglycan, 
and the DC's resistance to sonication), and the fact experimentally identified OMPs of 
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other pathogens (153) were not predicted correctly, suggests some A. phagocytophilum 
OMPs will also need to be verified by experimentation in addition to predictions.   
 Having the sequenced genome is a crucial step forward in the understanding of any 
pathogen.  Nevertheless, there are even more restrictions when applying this data directly 
towards the study of A. phagocytophilum.  One of the biggest limitations of working with 
A. phagocytophilum, as well as any obligate intracellular pathogen is direct genetic 
manipulation of the organism.  At this time, site-specific knockouts of genes are not a 
possibility.  A transposase system has been successfully utilized to insert GFP randomly 
into the A. phagocytophilum chromosome (50), suggesting promise for better genetic tools 
in the future.  Even if genetic manipulations were possible, the small genome of 1.47 Mb 
suggests that many genes may be essential for obligate intracellular survival.  If an 
essential gene of A. phagocytophilum such as an adhesin was disrupted, the mutant would 
not survive and could not be isolated for validation or characterization as it could not be 
isolated and grown under any other conditions.   
 Since direct genetic manipulation of A. phagocytophilum is not an option for 
experimentation, it means that any putative surface protein/adhesin will have to be tested 
by traditional methods.  This will entail expressing a protein in recombinant form, 
generating antiserum, and testing the antiserum to confirm expression and localization of 
the protein to the outer membrane.  Regardless, computer predictions are still valuable 
data, therefore other members of the Carlyon lab have compared these lists to other 
experimental data (55, 128) and are working on expressing some of the predicted proteins 
of interest.  Because it is impractical to express great numbers of potential membrane 
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proteins in recombinant form, as these are still just predictions, the focus of my dissertation 
project was to test other approaches to directly identify OMPs as potential adhesins of A. 




TIGR predicted cell envelope genes of unknown function.  A. phagocytophilum (strain 
HZ) genome (45) is divided into 25 gene role categories (http://cmr.jcvi.org/cgi-
bin/CMR/shared/GetNumAndPercentGenesInARole.cgi).  The cell envelope category 
consists of 163 (11.9% of the genome) proteins.  All 43 proteins (excluding the Msp2[P44] 
paralogs) of unknown function in the sub role of "other" were selected for analysis.   
 
CELLO and PSORTb outer membrane protein computer prediction programs.  The 
entire Ap genome in the protein FASTA format (http://www.ncbi.nlm. 
nih.gov/sites/entrez?db=genome&cmd=Retrieve&dopt=Protein+Table&list_uids=19215 
Display: protein FASTA) was copied and pasted into CELLO program v2.5: 
(http://cello.life.nctu.edu.tw/) (196).  Gram-negative organisms and protein sequences 
parameters were selected and submitted.  All potential OMPs were listed.  CELLO is a 
multi-class support vector machine classification system. Support vector machines are 
learning-based classifiers trained to classify proteins as belonging to a specific localization 
site.  CELLO uses a single module, based on multiple feature vectors that analyze n-
peptide compositions to predict the subcellular localization for Gram-negative bacteria.  
CELLO analyzes 4 types of sequence coding schemes; the amino acid composition, the di-
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peptide composition, the partitioned amino acid composition and the sequence composition 
based on the physico-chemical properties of amino acids.  Scores from these classifications 
determine the proteins final location.  
 The program PSORTb v3.0 (http://www.psort.org/) (197) was  used to analyze the 
Ap genome.  PSORTb Version 3.0 has the Ap (strain HZ) genome computed 
(http://db.psort.org/browse/genome?id=7470).  All predicted outer membrane proteins 
were listed.  The confirmed and the well documented outer membrane Msp2(P44) protein 
was excluded from all results.  PSORTb comprises six modules to examine protein 
sequence.  The modules are listed as follows: (1) SCL-BLAST & SCL-BLASTe, searches 
proteins against the database of proteins of known subcellular localization.  (2) Support 
Vector Machines, are machine learning-based classifiers trained to classify a protein as 
belonging or not belonging to the set of proteins at a specific localization site.  (3) Motif & 
Profile Analysis relies on the observation that a proteins function is closely linked to its 
localization.  (4) Outer Membrane Motif Analysis uses motifs generated from data mining 
applied to a set of 425 beta-barrel proteins to classify a query protein as outer membrane or 
non-outer membrane.  (5) ModHMM identifies transmembrane alpha helices, which in turn 
identifies proteins spanning the cytoplasmic membrane.  (6) Signal Peptide directs a 
protein for export past the cytoplasmic membrane, and can be used to differentiate 
cytoplasmic and non-cytoplasmic proteins.  The proteins final location is derived from a 





CHAPTER 4:  Crosslinking and Affinity Purification Approaches to 




 As a more direct means to identify A. phagocytophilum surface proteins as PSGL-1 
adhesins, we next chose to test several affinity capture approaches.  A. phagocytophilum 
recognition of the sLex-modified PSGL-1 N-terminus is a very specific interaction, which 
could serve as a means to potentially purify the respective adhesin(s).  Affinity purification 
allows for the enrichment of a variety of molecules, such as receptor-adhesin, enzyme-
substrate and antibody-antigen interactions from complex mixtures (9, 177).  Affinity 
based approaches using overlays and pull-downs have identified rickettsial adhesins (111, 
146) and a heparin binding outer membrane protein of Chlamydia (162).  A 
complementary approach that has also been successful in identifying molecular 
interactions is chemical crosslinking (120, 172).  The advantage of crosslinking is it allows 
for noncovalent or transient interactions to be captured, purified and then identified.  This 
type of approach successfully identified an adhesin of Helicobacter pylori that bound a 
fucosylated histo-blood group antigen (8, 86).   
 To identify adhesins by crosslinking and affinity purification we used 
commercially available recombinant human PSGL-1 (rhPSGL-1).  rhPSGL-1 is a 
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chimeric protein consisting of the extracellular domain of human PSGL-1 fused to the Fc 
region of human IgG1.  rhPSGL-1 contains all three receptor determinants essential for A. 
phagocytophilum binding as modeled in Figure 3B of Chapter 1.  An advantage of using 
rhPSGL-1 is the presence of the Fc receptor.  The Fc receptor will allow us to purify 
rhPSGL-1 with protein A/G beads, as the beads contain high affinity Fc-binding domains.  
Using the above approaches and reagents we set out to capture A. phagocytophilum sLex-
modified PSGL-1 targeting adhesin(s).   
 
RESULTS 
A. phagocytophilum binds immobilized but not soluble rhPSGL-1.    
 To assess under which conditions A. phagocytophilum binds PSGL-1, we tested 
bacterial adherence to rhPSGL-1 in soluble form, as well as to rhPSGL-1 immobilized to 
beads.  Even though only DC organisms bind PSGL-1 as demonstrated in Chapter 2, at the 
onset of this study there were no available techniques to separate RC and DC organisms 
from each other.  Therefore, we had to isolate and use total bacterial populations consisting 
of both RC and DC organisms for experiments.   
 We first tested the bacterium's ability to bind soluble rhPSGL-1 by mixing the two 
together, after which unbound rhPSGL-1 was washed away.  The bacteria were then 
solubilized, and the soluble fraction was mixed with Protein A/G beads to recover any 
rhPSGL-1 that had bound to the organisms.  The initial supernatant, washes and Protein 
A/G beads were analyzed by western blot for rhPSGL-1 (Fig. 13).  The greatest abundance 










Figure 13.  A. phagocytophilum does not bind soluble rhPSGL-1.  Three µg of  
rhPSGL-1 was mixed with A. phagocytophilum RC and DC organisms in PBS for 3 h.  
Organisms were pelleted and washed to remove unbound rhPSGL-1.  The initial 
supernatant removed from the bacterial pellet and the washes were checked for rhPSGL-1.  
The bacterial pellet was lysed in RIPA buffer and the soluble fraction was mixed with 
Protein A/G beads overnight to bind rhPSGL-1.  Protein A/G beads were recovered, boiled 
and the eluted sample was resolved by SDS-PAGE and examined by western blot for 
recovery of rhPSGL-1.  Any recovered rhPSGL-1 would indicate that A. phagocytophilum 
adhesin(s) can bind its receptor in soluble form.  Representative results of one of two 









































Figure 14.  A. phagocytophilum binds to rhPSGL-1 immobilized on beads.  Protein 
A/G beads were coated with (rhPSGL-1 coated) or without (uncoated) rhPSGL-1 and 
blocked with 5% BSA/PBS.  A. phagocytophilum RC and DC organisms were mixed in 
1% BSA/PBS with rhPSGL-1 coated and uncoated beads for 1 h.  Beads were pelleted and 
washed to remove unbound organisms, then lysed in RIPA buffer to solubilize any 
remaining bound organisms.  Samples were resolved by SDS-PAGE and examined by 
western blot for Msp2(P44) to determine if organisms bound to the beads.  The initial 
supernatant, washes and beads were checked for organisms.  A. phagocytophilum lysate 
served as a positive (Pos.) control for Msp2(P44) detection.  Representative results of one 


































washes nor was any recovered by the Protein A/G beads, suggesting that A. 
phagocytophilum adhesin(s) cannot bind soluble rhPSGL-1.  Under reducing conditions 
rhPSGL-1 typically migrates around 125 kDa, but occasionally multimers around 250 kDa 
can still be detected (Fig 13). 
 We next tested the organism's ability to bind rhPSGL-1 immobilized on Protein 
A/G beads.  Protein A/G beads were mixed with rhPSGL-1, resulting in Protein A/G 
binding to the IgG1 Fc receptor fused to rhPSGL-1, thus coating the beads with rhPSGL-1.  
Beads coated with (rhPSGL-1 coated) and without (uncoated) rhPSGL-1 were blocked in 
BSA and then mixed with A. phagocytophilum.  After 1 h, the supernatant was removed 
and the beads were washed and analyzed by western blot for organisms bound to the beads 
(Fig. 14).  A. phagocytophilum could be detected specifically binding to the beads coated 
with rhPSGL-1, whereas organisms did not bind to beads that lacked rhPSGL-1 
(uncoated).     
 
Crosslinking approach to capture A. phagocytophilum PSGL-1 adhesins. 
 Having determined that A. phagocytophilum organisms bind rhPSGL-1 
immobilized to Protein A/G beads, we next sought to use this binding event in adjunct with 
chemical crosslinking.  The principle of the approach is to allow organisms to bind 
rhPSGL-1, at which time a crosslinker is added to form a covalent bond between rhPSGL-
1 and bacterial adhesin(s).  The advantage of this approach is binding occurs in a native 
state.  Two commercially available crosslinkers, Dithiobis(sulfosuccinimidylpropionate) 










Figure 15.  Crosslinkers utilized during study.  Two commercially available crosslinkers 
were used in this study.  (A) DTSSP is a homobifunctional NHS-ester primary amine-
reactive crosslinker with a spacer arm length of 12 angstroms (Å).  (B) Sulfo-SDAD is a 
heterobifunctional crosslinker.  The NHS-ester reacts with primary amines, whereas the 
diazirine ring when exposed to UV light creates a reactive carbene intermediate to form a 
covalent bond with any amino acid side chain or peptide backbone within the spacer arm 
distance of 13.6 Å.  Both crosslinkers are water soluble and membrane impermeable.  Each 
crosslinker contains a disulfide bond, allowing for separation of any crosslinked proteins 



































Both crosslinkers contain n-hydroxysuccinimide-ester (NHS-ester) that react with amines, 
which are typically found in high abundance in proteins due to the amino acid lysine (172).   
 To identify adhesin(s) by crosslinking, we mixed A. phagocytophilum organisms 
with rhPSGL-1 coated or uncoated beads to allow for bacterial binding, followed by the 
addition of 5 or 10 mM DTSSP crosslinker to covalently crosslink A. phagocytophilum 
adhesin(s) to rhPSGL-1.  Bacteria were solubilized, leaving the crosslinkers' covalent bond 
between any adhesin(s) and rhPSGL-1 intact.  Beads with rhPSGL-1 still bound along with 
any crosslinked adhesin(s) were recovered.  The recovered beads were analyzed by two 
methods to determine if adhesin(s) were captured with crosslinking (Fig. 16).   
 We first boiled the recovered beads under reducing (with BME) conditions to break 
the disulfide bond of the crosslinker to release any adhesin(s) from rhPSGL-1.  Samples 
were resolved by SDS-PAGE gel and stained with Sypro Ruby protein stain (Fig. 16A) 
which has a sensitivity of 1 nanogram (ng), to detect any recovered adhesin(s).  All 
samples including the negative control of uncoated beads, to which A. phagocytophilum 
cannot bind and which no crosslinker was incubated, looked identical.  We determined that 
the BSA that is required to block the beads and achieve specificity of A. phagocytophilum 
binding to rhPSGL-1, is boiled off the beads resulting in very high background staining.  
The prominent band of 66 kDa, the known size of BSA, as well as several other BSA 
breakdown products are detected.  Because of the high background caused by BSA, we 
cannot exclude the possibility it could be masking recovered adhesin(s) of low abundance.  
As an alternative, we boiled the recovered beads under nonreducing conditions (No BME) 







Figure 16.  A. phagocytophilum adhesins are not crosslinked to rhPSGL-1 by DTSSP.  
Protein A/G beads were coated (rhPSGL-1 coated) with or without (uncoated) rhPSGL-1 
and blocked with 5% BSA/PBS.  A. phagocytophilum RC and DC organisms were mixed 
in 1% BSA/PBS with rhPSGL-1 coated or uncoated beads for 1 h.  Beads were washed to 
remove unbound organisms followed by the addition of 5 or 10 mM DTSSP crosslinker to 
covalently crosslink A. phagocytophilum adhesin(s) bound to or within proximity of 
rhPSGL-1.  Samples were lysed in RIPA buffer to solubilize the bacteria, which does not 
disturb the covalent bonds between any adhesin(s) crosslinked to rhPSGL-1.  Beads were 
then washed and recovered (rhPSGL-1 remains bound to beads along with any crosslinked 
adhesins).  Samples were analyzed by Sypro Ruby protein stain (A) and western blot (B).  
(A) Recovered beads were boiled under reducing (with BME) conditions to elute any 
recovered A. phagocytophilum adhesin(s) crosslinked to rhPSGL-1 and resolved by SDS-
PAGE gel.  Gel was stained with Sypro Ruby protein stain and examined for recovered 
proteins.  Uncoated beads serve as the negative control.  Representative results of one of 
two separate experiments are shown.  (B) Recovered beads were boiled under non-
reducing (No BME) conditions to elute rhPSGL-1 from beads along with any attached 
adhesin(s).  Samples were analyzed by western blot to detect any shifts in rhPSGL-1, 
which would indicate crosslinking had occurred.  Uncoated beads serve as the negative 






























adhesin(s).  Samples were resolved by SDS-PAGE gel and analyzed by western blot (Fig. 
16B) to look for shifts in rhPSGL-1, which would indicate crosslinking of rhPSGL-1 to an 
adhesin(s) occurred.  No shifts in rhPSGL-1 were detected.  We also tested by western blot 
and determined that not even the dominant (Msp2[P44]) surface protein of A. 
phagocytophilum, was recovered with DTSSP crosslinking (data not shown).   
 A variety of alternatives conditions were taken to try and troubleshoot these 
approaches (data not shown).  These included blocking rhPSGL-1 coated beads with dry 
milk, and testing bacterial binding in the presence of tween-20, neither of which were 
successful.  One disadvantage of using the DTSSP crosslinker is its dependence on free 
amines for crosslinking.  Because we do not know the surface characteristics of A. 
phagocytophilum, we cannot exclude the possibility there are only a few accessible amines.  
Therefore we tested the Sulfo-SDAD crosslinker (Fig. 15B) which can react with primary 
amines and any amino acid side chain or peptide backbone.  We allowed organisms to bind 
rhPSGL-1 coated beads, then added Sulfo-SDAD post binding.  Alternatively, we labeled 
organisms with the amine reactive end of Sulfo-SDAD, allowed the organisms to bind 
rhPSGL-1 coated beads, then activated the diazirine ring.  Sulfo-SDAD was also 
unsuccessful (data not shown).   
 
Immunoprecipitation approach to capture A. phagocytophilum PSGL-1 adhesins. 
 Since crosslinking was unsuccessful in capturing adhesin(s), we next tested 
immunoprecipitation (IP) as an alternative approach to identify A. phagocytophilum 










Figure 17.  Immunoprecipitation was unsuccessful in recovering A. phagocytophilum 
adhesins.  Protein A/G beads were coated (rhPSGL-1 coated) with or without (uncoated) 
rhPSGL-1.  A. phagocytophilum DC-enriched organisms or HL-60 controls were lysed in 
non-denaturing lysis buffer and incubated with beads overnight.  Beads were washed to 
remove unbound proteins and then boiled under reducing conditions to elute any 
adhesin(s) bound to rhPSGL-1.  Samples were resolved by SDS-PAGE gel and stained 
with Sypro Ruby to detect recovered proteins.  The A. phagocytophilum DC-enriched 
lysate mixed with rhPSGL-1 coated beads was resolved in the far right lane.  



































sonication of infected cells, which destroy the fragile RC and leave the resistant DC intact 
(79).  DC-enriched organisms were recovered and lysed in non-denaturing lysis buffer.  
The soluble fraction was then mixed overnight with rhPSGL-1 coated beads.  Beads were 
recovered, washed to remove unbound proteins and boiled to elute any captured adhesin(s).  
Samples were resolved by SDS-PAGE gel and stained with Sypro Ruby (Fig. 17).  
Because we did not use intact organisms in this experiment it was not necessary to block 
the beads with BSA, so we did encounter the high background issues as with the 
crosslinking approach.  We did not detect any recovered proteins with this approach.  A 
prominent band of 125 kDa (known size of rhPSGL-1) is detected, as well as several other 
rhPSGL-1 breakdown products.  The non-denaturing lysis buffer is sufficient in lysing DC-
enriched organisms as the prominent surface protein Msp2(P44) is detected in the lysate 
control.  This approach was also tested with A. phagocytophilum DC lysates generated 
with denaturing lysis buffer, but was also unsuccessful. 
 
DISCUSSION 
 Our data was able to demonstrate that A. phagocytophilum organisms only adhere 
to PSGL-1 immobilized on a surface.  It is not surprising that A. phagocytophilum adhered 
to rhPSGL-1 coated beads, as these beads fundamentally mimic HL-60 cells, to which A. 
phagocytophilum readily binds (173).  A. phagocytophilum can also bind PSGL-1 
glycopeptides immobilized on beads (194), and others in the Carlyon lab determined that 
A. phagocytophilum binds rhPSGL-1 coated to the well of an enzyme-linked 
immunosorbent assay (ELISA) plate (unpublished data).  Although we used both RC and 
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DC organisms in many of these binding experiments, we are confident that only DC 
organisms bind to   rhPSGL-1.   
 Even though we were unsuccessful in identifying adhesins by crosslinking, it is an 
ideal approach as it allows organisms to bind their receptor in a natural state.  Other than 
the accessibility of binding sites on proteins for the crosslinker, they have no bias or 
selective conditions in which to crosslink proteins.  As long as two proteins with free 
amines are in close enough proximity, they should become crosslinked.  Both DTSSP and 
Sulfo-SDAD were tested on A. phagocytophilum organisms and shifts in Msp2(P44) were 
detectable by western blot (data not shown).  This indicates the crosslinkers were properly 
functioning and that Msp2(P44) has accessible amines.  The extreme N-termini of 
rhPSGL-1 is in close proximity to the region where A. phagocytophilum organisms bind, 
which should have been ideal for crosslinking.  Crosslinkers should have been sufficient to 
recover both soluble and insoluble proteins.  The αPSGL-1 Ab (KPL-1) is extremely 
sensitive and can detect as little as 0.05 µg of protein (unpublished data).  Even if 
adhesin(s) were recovered in low abundance, shifts in rhPSGL-1 should have been 
detectable (Fig. 16B).   
 There are several reasons why crosslinking may have been unsuccessful.  First, 
when A. phagocytophilum organisms bind PSGL-1, it may do so in a manner where the 
whole organism sterically hinders accessibility of the crosslinker from gaining access to 
the receptor-adhesin interaction site.  Second, free amines have to occur within the distance 
of the spacer arm of the crosslinker for crosslinking to occur.  If the crosslinker is too 
short, and there are not enough accessible amines within proximity of each other, 
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crosslinking will not occur.  This should have been less of a problem with the crosslinker 
Sulfo-SDAD, as it binds amines at one end and any amino acid at the other end.  
Nevertheless, use of the crosslinker post binding and labeling organisms pre binding to 
rhPSGL-1 was unsuccessful in recovering adhesin(s).  Others in the Carlyon lab also tested 
labeled rhPSGL-1 with crosslinkers first, allowed organisms to bind, then activated the 
crosslinker to capture adhesin(s) (unpublished data).  This approach was also unsuccessful.   
 The use of bacterial lysates has also proven to be equally important in identifying 
adhesins (111, 146).  The biggest limitation of this approach is the adhesin(s) have to be 
soluble, as all insoluble material from lysates is discarded.  Given the resistant properties 
of the A. phagocytophilum DC, we cannot exclude the possibility some surface proteins are 
insoluble and not recovered.  However, the facts soluble bacterial lysates did not bind 
rhPSGL-1 (Fig. 17) and intact organisms did not bind soluble rhPSGL-1 (Fig. 13) suggest 
the affinity of the adhesin or receptor interaction in soluble form is too weak to occur.  
When intact organisms bind immobilized PSGL-1 it is a specific and strong interaction.  
We believe that multiple adhesins may be involved in binding, but we do not know the 
affinity of a given adhesin for its respective receptor determinant.  A specific adhesin-
receptor interaction could be individually weak, but the synergistic effect of all the 
adhesins working together may support strong binding of intact organisms.  If this were 
true, once the adhesins are isolated from the membrane they may not have a strong enough 
affinity for their individual receptor determinants to be isolated and identified.   
 The structural requirements required for binding at this time are also unknown.  We 
cannot exclude the possibility that an adhesin could be a complex of proteins.  Surface 
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proteins within a heterodimer complex of the veterinary pathogen A. marginale were found 
to be an adhesin for erythrocytes (21, 38, 91).  If a complex of proteins is required for A. 
phagocytophilum binding, this will be disrupted when generating lysates.  We also cannot 
exclude the importance of protein conformation during binding.  When P-selectin binds 
sialic acid on PSGL-1, a conformational epitope is required (161).  It is possible that the 
structural requirements of the adhesin required for binding sLex-modified PSGL-1 is only 
found on intact organisms and when denatured may result in the loss of adhesin activity.  
Non-denaturing lysis buffers should increase the chance of recovering proteins in a native 
state with IPs (22), but did not appear successful when tested with A. phagocytophilum 
(Fig. 17).  
 In conclusion, we determined adherence of A. phagocytophilum to sLex-modified 
PSGL-1 must occur on a fixed surface, whether it is HL-60 cells, beads or ELISA plates.  
The data presented here as well as other unpublished data from the Carlyon lab, 
demonstrates known methods used in the recovery of other bacterial adhesins were 
unsuccessful in recovering A. phagocytophilum adhesins.  A. phagocytophilum adhesion to 




Mixing soluble rhPSGL-1 with A. phagocytophilum.  Ap RC and DC organisms (strain 
NCH-1) were recovered by syringe lysis as described (27) from 200 ml of culture and 
mixed in a total of 100 microliters (µl) PBS containing 3 micrograms (µg) rhPSGL-1 
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(R&D Systems; Minneapolis, MN, Cat. No. 3345-PS) with protease inhibitors (Roche; 
Indianapolis, IN, Cat. No. 118361153001) for 3 h at 4°C with rotation.  Bacteria were 
pelleted at 10,000 x g for 6 min at 4°C and were washed 2 times with 1 ml cold PBS 
(supernatant from initial spin and washes were saved for western blot analysis).  Bacteria 
were lysed in 1 ml of radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris pH 7.4, 
1% Nonidet P-40, 0.25% sodium deoxycholate, 150 mM sodium chloride [NaCl], 1 mM 
EDTA, 1 mM sodium orthovanadate [Na3VO4] and 1mM sodium fluoride[NaF]) with 
protease inhibitors for 45 min on ice.  Insoluble material was removed at 10,000 x g for 10 
min after which the soluble fraction was mixed with 25 µl of Protein A/G beads (Pierce; 
Waltham, MA, Cat. No. 20421) overnight (O/N) at 4°C with rotation.  Beads were pelleted 
at 3,000 x g at 4°C for 1 min and washed with 1 ml cold PBS 3 times.  Forty µl of 
Laemmli 2X sample buffer (Bio-Rad; Hercules, CA, Cat. No. 161-0737) with 5% BME 
(Fisher Scientific; Pittsburgh PA, Cat. No. BP176-100) was added to beads and boiled for 
5 min at 100°C.  Beads were pelleted at 3,000 x g for 1 min, supernatant was saved and 
analyzed for rhPSGL-1.  25 µl of supernatant (wash steps) was mixed with equal volumes 
of 2X sample buffer with 5% BME and boiled for 5 min at 100°C.   
 Samples were resolved on 4-15% Tris-HCl gel (Bio-Rad Cat. No. 161-1158) at 
115v for 15 min and 130v for 45 min and then transferred to nitrocellulose at 100v for 1 h.  
The blot was blocked in 5% milk in tris-buffered saline with 5% tween-20 (TBS-t[0.5%]) 
O/N at 4°C.  Primary antibody (Ab) mouse anti-PSGL-1 (KPL-1) (BD Pharmingen; San 
Diego, CA, Cat. No. 556053) was added at room temperature (RT) for 1 h at 1:2,000 
dilution in 1% milk-TBS-t(0.5%).  The blot was washed for 5, 5, 15, 5, and 5 min in TBS-
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t(0.5%).  Secondary Ab anti-mouse IgG horseradish peroxidase (HRP)-conjugated (Cell 
Signaling; Danvers, MA, Cat. No. 7076) was added at RT for 1 h at 1:30,000 dilution in 
1%  milk-TBS-t(0.5%).  The blot was washed for 5, 5, 15, 5, and 5 min in TBS-t(0.5%).  
The blot was incubated with SuperSignal West Pico chemiluminescent substrate (Pierce, 
Cat. No. 34080) for 5 min and exposed to film (Pierce, Cat. No. 34091).  
 
A. phagocytophilum binding to Protein A/G beads coated with rhPSGL-1.  10 µg of 
rhPSGL-1 was mixed with 25 µl of Protein A/G beads in 1 ml PBS with protease inhibitors 
O/N.  The next day, beads were pelleted at 3,000 x g for 30 seconds (sec) and supernatant 
discarded.  1 ml of 5% bovine serum albumin (BSA)/PBS was added for 1 h at RT with 
rotation to block beads.  Uncoated beads were prepared in same manner without the 
addition of rhPSGL-1.  Ap RC and DC organisms (strain NCH-1) were recovered by 
syringe lysis as described (27) from 120 ml of culture and split equally with rhPSGL-1 
coated and uncoated beads in 1 ml of 1% BSA/PBS for 1 h at RT with rotation.  Beads 
were pelleted at 1,000 x g for 1 min at RT and washed 3 times with 1 ml PBS.  Supernatant 
from initial spin and washes were saved and centrifuged at 10,000 x g for 6 min to test for 
Ap.  rhPSGL-1 coated, uncoated beads and Ap recovered from supernatant and washes 
were lysed in 250 µl of RIPA buffer with protease inhibitors for 45 min on ice.  Insoluble 
material and beads were removed by spinning at 10,000 x g for 10 min.  Twenty-five µl of 
supernatants were mixed with 25 µl of Laemmli 2X sample buffer with 5% BME and 
boiled for 5 min at 100°C.   
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 Samples were resolved on 4-15% Tris-HCl gel at 115v for 15 min and 130v for 45 
min and transferred to nitrocellulose at 100v for 1 h.  Blot was blocked in 5% milk-TBS-
t(0.5%) O/N at 4°C.  Primary Ab rabbit anti-Ap was added at RT for 1 h at 1:10,000 
dilution in 1 % milk-TBS-t(0.5%).  The blot was washed for 5, 5, 15, 5, and 5 min in TBS-
t(0.5%).  Secondary Ab anti-rabbit IgG HRP-conjugated (Cell Signaling, Cat. No. 7074) 
was added at RT for 1 h at 1:20,000 dilution in 1 % milk-TBS-t(0.5%).  The blot was 
washed for 5, 5, 15, 5, and 5 min in TBS-t(0.5%).  The blot was incubated with 
SuperSignal West Pico chemiluminescent substrate for 5 min and exposed to film. 
 
Crosslinking A. phagocytophilum adhesins to rhPSGL-1 with DTSSP.  Ap (strain 
NCH-1) was mixed with rhPSGL-1 coated and uncoated beads as described above.  
Unbound organisms were washed off  and beads were split equally into two samples and 
resuspended in 1 ml of 5 or 10 mM DTSSP (Pierce, Cat. No. 21578) for rhPSGL-1 coated 
beads or PBS and 5 mM DTSSP for uncoated beads and incubated for 30 min at RT with 
rotation.  Tris was added to a final concentration of 20 mM for 15 min to quench 
crosslinker.  Beads were pelleted at 1,000 x g for 1 min at RT, and washed with 1 ml cold 
PBS.  Beads were lysed in 250 µl RIPA buffer with protease inhibitors for 45 min on ice.  
Beads (with rhPSGL-1 still bound) were pelleted at 1,000 x g for 1 min and washed 4 
times in 1 m of cold PBS.  40 µl of Laemmli 2X sample buffer with 10% BME was added 
and boiled for 5 min at 100°C.   
 Beads were pelleted at 3,000 x g for 1 min, supernatant was saved and analyzed for 
recovery of Ap adhesin(s).  Samples were resolved on 4-15% Tris-HCl gels at 115v for 15 
 
 96 
min and 130v for 45 min.  Gels were stained with Sypro Ruby (Invitrogen; Carlsbad, CA, 
Cat. No. S-12000) according to manufactures instructions and imaged with trans UV on 
ChemiDoc XRS imager (Bio-Rad).  In some experiments, samples were eluted from beads 
under non-reducing conditions (No BME), resolved by SDS-PAGE and transferred to 
nitrocellulose at 100v for 1 h.  Blots were screened with α PSGL-1 (KPL-1 Ab) as 
described above. 
 
Immunoprecipitation with rhPSGL-1 coated beads using non-denatured A. 
phagocytophilum lysate.  rhPSGL-1 coated and uncoated beads were prepared as 
described above.  Ap DC-enriched organisms (strain NCH-1) were recovered from 400 ml 
of culture by sonication as described (79).  Ap was lysed in 1 ml of non-denaturing lysis 
buffer (1% w/v Triton-X-100, 0.02% w/v sodium azide, 50 mM Tris-HCl pH 7.4, 300 mM 
NaCl, 5 mM EDTA, 10 mM iodoacetamide, 2 µg/ml leupeptin and 1 mM 
phenylmethylsulfonyl fluoride [PMSF]) at 4°C for 45 min with rotation.  Insoluble 
material was removed by spinning at 10,000 x g for 10 min.  Supernatants were split 
equally among samples.  Equal numbers of uninfected HL-60 cells were prepared in the 
same manner as infected cells to serve as negative controls.  All samples were mixed with 
rhPSGL-1 coated or uncoated beads in a total of 1 ml non-denaturing lysis buffer O/N at 
4°C with rotation.  The next day, beads were pelleted at 1,000 x g for 1 min and washed 3 
times with 1 ml cold PBS.  40 µl of Laemmli 2X sample buffer with 5% BME was added 
to the washed beads and boiled for 5 min at 100°C.  Beads were pelleted at 3,000 x g for 1 
min, supernatant was saved and analyzed for recovery of Ap adhesin(s).  Samples were 
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resolved on 4-15% Tris-HCl gels at 115v for 15 min and 130v for 45 min.  Gels were 
stained with Sypro Ruby according to manufactures instructions and imaged with trans UV 







CHAPTER 5:  Identification of Putative A. phagocytophilum Dense-
Cored Cell Outer Membrane Proteins by Density-gradient 




 In view of the fact that we were unable to capture or purify A. phagocytophilum  
adhesins by receptor crosslinking and affinity purification, we next chose to take a broader 
approach to identify OMPs of the adherent DC.  The biphasic development cycle exhibited 
by A. phagocytophilum was first documented to occur and is most well studied in 
Chlamydia species.  For some research purposes, it is essential to purify these intracellular 
bacteria away from their host cell components.  Separation of the noninfectious RB and 
infectious EB developmental forms of Chlamydia from each other and removal of host cell 
debris has been accomplished by the use of Renografin density-gradient centrifugation (99, 
156).  Separation of different developmental forms and removal of host cell debris with 
density-gradient centrifugation has also been accomplished for intracellular pathogens 
within the order Rickettsiales as well as for Coxiella burnetii (65, 187-190, 198). 
 Due to the relatively recent discovery of human infections in 1994 (34), 
standardized techniques in use for other organisms have not yet been fully developed for 
the study of A. phagocytophilum.  An example is the inability thus far to separate the A. 
phagocytophilum replicative RC and the adherent DC forms from each other.  To date, 
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Renografin density-gradient centrifugation has only been able to separate both RC and DC 
organisms mixed together from host cell debris (27).  To identify OMPs of the adherent 
DC form we chose to use the sonication resistant properties of the DC for their selection, 
followed by Renografin discontinuous density-gradient centrifugation to remove host cell 
debris.  We then used biotinylation to label surface proteins, a proven method previously 
validated to work with A. phagocytophilum and other organisms (25, 55, 88, 138, 141, 
153).  Biotinylated OMPs were purified and then identified by mass spectrometry (MS).   
 
RESULTS 
The A. phagocytophilum dense-cored cell is resistant to sonication. 
 The infectious EB of Chlamydia is very environmentally resistant and stable due to 
extensive crosslinking of disulfide bonds within its membrane (67).  The EB's stability 
allows it to survive treatments with both detergents and sonication that destroy the fragile 
replicative RB (68, 156, 167).  To determine if the A. phagocytophilum DC is 
environmentally resistant, we compared the conventional isolation method of syringe lysis 
to sonication.  Samples were monitored for RC and DC organisms by TEM before 
isolation, after syringe lysis and after sonication.   
 Organisms for experiments are isolated from cultures of asynchronously infected 
cells (Fig. 18A) containing both RC and DC organisms.  The abundance of RC and DC 
organisms in a given culture before use in experiments cannot be determined at this time, 
as there are no antibodies or differently expressed markers to distinguish between the two 











Figure 18.  A. phagocytophilum organisms at various stages of isolation examined by 
transmission electron microscopy.  (A) Infected HL-60 cells.  Infected cells containing 
both RC and DC organisms are the starting material for all experiments.  (B) Syringe lysis.  
Both RC and DC organisms mixed with some host cell debris were recovered by syringe 
lysis.    (C) Sonication.  Infected cells were sonicated to destroy the host cell and fragile 
RC organisms, leaving the environmentally resistant DC intact.  White arrowheads denote 



































infection, the best time to recover the greatest abundance of organisms is late in infection 
after the culture has become asynchronous and the cells are heavily infected (Fig. 8B).  
The population of the DC in these asynchronous cultures is approximately 30-55% (Table 
1).  The standard method of isolating A. phagocytophilum for experiments is syringe lysis.  
We observed that this method is best suited for recovery of a mixture of both RC and DC 
organisms, which is also mixed with host cell debris (Fig. 18B).  To test whether or not the 
A. phagocytophilum DC is environmentally resistant, former Carlyon lab member Nathan 
Galloway sonicated infected cells from 32 up to160 sec.  The DC was able to remain 
visually intact even after 160 sec of sonication as observed by TEM (data not shown).  We 
chose to use 64 sec of sonication for experiments as this was the minimum time required 
for destruction of the host cells and RC organisms (Fig. 18C).  
 
Renografin purification and biotinylation of A. phagocytophilum DC OMPs. 
 Establishing that sonication was an efficient means to destroy RC organisms while 
leaving the DC form intact, we next used this technique in combination with the published 
protocol of Renografin discontinuous density-gradient centrifugation (27) to purify the DC 
organisms and reduce the amount of cellular debris.  Figure 19A is a representative TEM 
image of sonicated DC organisms recovered after Renografin purification.   
 The purified DC organisms were then mixed with an excess of the water soluble, 
non-membrane permeable Sulfo-NHS-SS-Biotin to label OMPs.  Bacteria were solubilized 










Figure 19.  Density-gradient purified DC organisms and recovered biotinylated 
putative surface proteins.  Infected cells were sonicated to enrich for DC organisms, and 
then purified by Renografin discontinuous density-gradient centrifugation.  (A) TEM 
image of DC organisms recovered between the 30% - 42% Renografin interface.  Grey 
arrows denote DC organisms.  Scale bar 1 µm.  (B) Renografin density-gradient purified 
DC OMPs were labeled with the non-membrane permeable Sulfo-NHS-SS-Biotin.  
Bacteria were lysed in RIPA buffer and soluble biotinylated proteins were purified with 
NeutrAvidin Beads.  Recovered biotinylated proteins were resolved by SDS-PAGE and 
examined by silver stain (lane 1).  A whole cell lysate control was resolved in lane 2.  The 
dominant Ap surface protein Msp2(P44) is indicated.  Representative results of one 


































biotinylated proteins.  Recovered proteins were resolved by SDS-PAGE and examined by 
silver stain.  Selective enrichment of specific proteins can be observed in lane 1 when 
compared to the whole cell lysate control of lane 2 (Fig. 19B).  The dominant A. 
phagocytophilum surface protein Msp2(P44) is clearly enriched with biotinylation, as 
would be expected due to its known surface localization.   
 
Identification of recovered proteins by mass spectrometry.   
 To identify recovered A. phagocytophilum proteins, we chose to use a type of MS 
referred to as multi-dimensional protein identification technology (MudPIT).  MudPIT is 
suited to identify hundreds of proteins from complex mixtures (108).  It allows peptides to 
be separated by 2D liquid chromatography, thus eliminating the need to resolve samples by 
gels.  From our biotinylation approach, MudPIT identified a total of 55 A. 
phagocytophilum proteins (Table 5).  However, only 16 of these proteins can be 
confidently accepted as an authentic result with a 1% chance of error.  For proteins to be 
considered authentic they should have a confidence score of above 300 with several 
recovered peptides.  Proteins below this threshold have a higher probability of being a false 
positive.  MudPIT also confidently identified 153 human proteins (data not shown), 
indicating that the sample still had considerable host cell debris contamination.   
 
DISCUSSION 
 Our data demonstrates that the A. phagocytophilum DC is environmentally resistant 
and is capable of surviving mechanical means of disruption, a property that we were able 
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Table 5.  Putative Ap biotinylated OMPs identified by MudPIT 
 
Ap gene kDaa Protein description Score Peptides Coverageb 
1 APH_1221 45.8 P44 18ES OMP 20,608 131 78 
2 APH_1235 14.7 hypothetical protein 4,191 33 92 
3 APH_0240 58.2 chaperonin GroEL  1,437 69 69 
4 APH_0494 51.5 ATP synthase subunit   641 32 59 
5 APH_0405 57.5 hypothetical protein (Asp55)  490 27 46 
6 APH_1087 26.1 putative  lipoprotein  458 10 37 
7 APH_1032 42.8 elongation factor Tu  415 19 45 
8 APH_1190 18.8 ATP synthase subunit  415 2 14 
9 APH_0404 63.6 hypothetical protein (Asp62) 413 21 27 
10 APH_0397 32.1 30S ribosomal protein S2  406 12 33 
11 APH_0036 22.6 co chaperone GrpE  395 4 33 
12 APH_1404 46.9 T4SS protein  VirB10  389 8 23 
13 APH_0346 69.7 chaperone protein DnaK  381 25 34 
14 APH_0248 13.8 hypothetical protein  359 10 58 
15 APH_1049 23.3 major surface protein 5  354 4 22 
16 APH_1334 54.1 ATP synthase subunit alpha  312 30 35 
17 APH_0051 37.3 iron binding protein  253 4 15 
18 APH_0853 10.8 hypothetical protein  250 4 63 
19 APH_0625 34.7 immunogenic protein  229 6 29 
20 APH_1050 37.6 putative ABC transporter  221 3 17 
21 APH_1246 52.4 glutamine synthetase type I  216 9 10 
22 APH_1232 45.6 citrate synthase I  214 5 20 
23 APH_0600 61.5 thiamine biosynthesis - ThiC  203 4 11 
24 APH_0059 39.2 phenylalanyl tRNA synthetase  197 7 14 
25 APH_0555 51.8 cysteinyl tRNA synthetase  193 5 19 
26 APH_0985 19.8 putative lipoprotein  185 1 14 
27 APH_0794 27.1 hypothetical protein  184 2 8 
28 APH_0740 131.1 ankyrin  183 11 7 
29 APH_1258 32.7 fructose bisphosphate aldolase  182 5 9 
30 APH_0723 27.2 hypothetical protein  182 1 3 
31 APH_1025 14.1 50S ribosomal protein L7 L12  181 2 24 
32 APH_1292 42.0 cell division protein FtsZ  181 3 13 
33 APH_1210 85.7 OMP85 family OMP  174 7 8 
34 APH_0130 20.6 triphosphate deaminase  172 1 5 
35 APH_0283 29.8 50S ribosomal protein L2  170 3 8 
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36 APH_0893 71.1 heat shock protein 90  168 6 13 
37 APH_1412 16.0 hypothetical protein  168 1 7 
38 APH_1217 15.6 nucleoside diphosphate kinase  167 1 10 
39 APH_0111 26.3 uridylate kinase  164 2 13 
40 APH_1151  21.4 hypothetical protein  162 1 5 
41 APH_0608 67.4 ppiC parvulin rotamase protein  161 10 13 
42 APH_1359 31.6 major  OMP 1A  158 2 6 
43 APH_1084 29.8 cytochrome c oxidase subunit II  155 3 13 
44 APH_0422 35.7 acetylglutamate kinase  152 2 7 
45 APH_0792 37.6 hypothetical protein 149 1 3 
46 APH_1219 33.4 Omp 1X  145 1 5 
47 APH_0971 49.4 putative trigger factor  141 3 13 
48 APH_0038 59.4 CTP synthetase  140 2 6 
49 APH_0669 114.5 proline dehydrogenase  139 4 7 
50 APH_0450 86.7 ATP dependent Clp protease  138 2 2 
51 APH_0386 58.6 HGE 14 protein  135 1 2 
52 APH_0231 54.6 leucyl aminopeptidase  129 3 11 
53 APH_0678 63.4 chaperone protein HscA  127 1 5 
54 APH_0393 49.0 dihydrolipoamide dehydrogenase  127 1 2 
55 APH_0874 115.4 hypothetical protein  123 5 3 
       Proteins above the dashed line are 99% authentic with only a 1% false-discovery rate 
          a Size of identified protein 
          b Percentage of protein coverage  











to use in its isolation.  The focus of this study was to identify surface proteins of the A. 
phagocytophilum DC, using improved purification approaches.  We observed several 
limitations when surface proteins of A. phagocytophilum were previously identified (55).  
First, both RC and DC organisms were used for OMP identification.  For our purposes, we 
only used the adherent DC organism in this study, as our goal is to identify OMPs as 
putative adhesins.  Second, some of previously identified proteins may not have been 
surface exposed if the biotin reagent gained access through functional porins (25) to label 
inner membrane proteins.  Although we did not control for this issue, it is unlikely to be a 
problem with DC organisms.  Porins function as a transport conduits through which 
various molecules such as nutrients can pass (130).  A. phagocytophilum has porins (80), 
but they are most likely only active on the RC during intracellular growth and replication.  
The sonication-resistant feature of the DC further demonstrates that its function is to 
survive harsh extracellular environments during dissemination.  It would be 
disadvantageous for the organisms to have functional porins outside the cell in a 
potentially hostile environment.  Indeed, the Coxiella small cell-variant (SCV) and 
Chlamydia EBs either down regulate proteins that function as porins or heavily crosslink 
the surface, thereby ceasing porin function on their respective infectious forms (17, 180).  
A third limitation of the previous study was that only a select few bands from a 1D SDS-
PAGE gel were chosen for analysis.  Our use of MudPIT, which does not require proteins 
to be resolved on a gel, eliminates any bias by detecting all recovered biotinylated proteins.  
 Previously, only 14 putative A. phagocytophilum surface proteins were identified 
with biotinylation (55), of which only 3 have been confirmed as surface localized.  Our 
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biotinylation approach of the DC recovered 55 proteins.  However, only 16 proteins could 
be confidently identified as an authentic result.  Of the proteins that we confidently 
identified, 3 were known surface proteins (Msp2[P44], Asp55 [APH_0405] and Asp62 
[APH_0404]).  Of all 55 proteins we potentially identified, 9 of these were identified in the 
previous study.  They were Msp2(p44), APH_0036, 0240, 0346, 0404, 0405, 0608, 1210 
and 1359.  All but 3 of these proteins (APH_0608, 1210 and 1359) were confidently 
identified in our analysis.  We also confidently identified Msp5 (APH_1049), a well 
conserved protein amongst Anaplasma species (163).   
 Even though our study corroborates the previous biotinylation study, some of the 
recovered proteins are not ones that would be expected to be surface exposed, while others 
appear to be missing.  A total of 3 chaperones GroEL (APH_0240), GrpE (APH_0036) and 
DnaK (APH_0346) were confidently identified.  Chaperones assist in protein folding in the 
cytoplasm (77), and would not be expected as surface exposed proteins.  The same is true 
of elongation factor Tu (APH_1032), which is associated with the ribosome (131).  As odd 
as it may be for these proteins to be surface exposed, some evidence not only suggests they 
are on the surface in some instances, but also act as adhesins.  Elongation factor Tu of 
Lactobacillus johnsonii has been demonstrated to mediate attachment to human intestinal 
cells and mucins (63).  Whereas GroEL of both Lactobacillus johnsonii and Plesiomonas 
shigelloides has also demonstrated adhesin function (19, 175).  It may be predicted that 
because the DCs chromatin is compacted, the organism is likely to be metabolically 
inactive and thus would not require chaperones.  Nonetheless, characterization of the 
proteome of the infectious Chlamydial EB has found many proteins associated with 
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metabolism, replication, and protein folding (159, 179).  These proteins are likely 
prepackaged in the infectious form so the organisms can quickly use them upon entry into 
a host cell for replication and intracellular survival.  Two other confidently identified 
proteins, APH_1235 and APH_0248 were of interest due to their small sizes of 14.7 and 
13.8 kDa, respectively.  It is interesting to speculate how such small proteins are integrated 
into the membrane.  Proteins such as these would not be predicted as OMPs, as their small 
size would prevent them from containing enough structural features to allow them to be 
classified as traditional membrane proteins.  One group of proteins that would have been 
expected to be recovered are the A. phagocytophilum T4SS components (133).  DCs 
should express the T4SS, as AnkA is delivered into host cells upon bacterial binding.  Of 
all the T4SS components, only VirB10 was detected.  VirB10 is predicted to localize 
within the inner membrane, yet all the outer membrane protein components of the T4SS 
(32), VirB2, VirB3, VirB5, VirB7 and VirB9 were not detected.  
 The unusual ability of A. phagocytophilum to bind human PSGL-1 suggest that the 
adhesin(s) are unusual as well.  Even though chaperones GroEL, GrpE , DnaK as well as 
elongation factor Tu may be unusual if they localize to the surface of A. phagocytophilum, 
it does not yet directly implicate them as adhesin(s).  Some of these proteins as well as 
predicted OMPs APH_1210 (OMP85 family) and APH_1359 (OMP 1A) have very high 
protein sequence homologies to other bacterial species (data not shown).  This raises the 
question of how could these proteins. if adhesin(s), achieve specificity of binding to   
PSGL-1 for A. phagocytophilum if also expressed on the outer membrane of other 
pathogens.  We presume that we are looking for unique proteins.  This would include 
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hypothetical proteins, as these proteins are predicted to existence, but for which there is no 
experimental evidence that they are expressed in vivo.  They can also have little homology 
to other proteins of known function.  The A. phagocytophilum genome contains 540 
hypothetical proteins, comprising 38.3% of the genome.   
 Overall, our approach of purification and biotinylation of the DC was successful in 
recovering known and potentially new OMPs.  However, there are several limitations of 
this experimental approach that will need to be addressed further for us to be confident that 
we are truly identifying DC specific OMPs.  One concern is the volume of contaminating 
cellular debris.  We confidently identified 153 human proteins (derived from HL-60 cells), 
but only 16 A. phagocytophilum proteins.  Debris contamination was visually observed by 
TEM as well (Fig. 19A).  An excess of debris could interfere with efficient labeling of 
OMPs on the DC, preventing recovery of low abundant proteins.  The published 
Renografin density-gradient centrifugation protocol has only been tested on recovering 
organisms from syringe lysis (27) and the purity of the organisms was never confirmed by 
TEM.  We did not take into consideration that sonication generates very fine debris 
particles that could not be readily removed.  We have since tried different sonication times 
and added more gradient layers, but were unsuccessful in eliminating debris from 
comigrating with A. phagocytophilum DC organisms.  A greater concern is whether or not 
this debris could contain destroyed RC organisms.  If debris from RC organisms 
comigrates with the DC, then we cannot be confident that the proteins we identified are 
truly DC-specific or even surface proteins.  It is possible that some identified proteins 
could be derived from the RC cytoplasm.  Indeed, one of the confidently identified 
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proteins was 30S ribosomal protein S2 (APH_0397).  Also, many of the proteins we 
identified, albeit of low confidence, are associated with metabolism.  Generally, these 
proteins would not be predicted to be surface exposed.  Another concern is we also have to 
question how efficient RIPA buffer extracts surface proteins from the membrane given the 
resistant nature of the A. phagocytophilum DC.  Although RIPA buffer is commonly used 
for lysing A. phagocytophilum and most certainly can solubilize surface proteins, the 
efficiency of extraction is unknown.  Msp2(P44) was easily recovered and confidently 
detected, yet predicted OMPs APH_1210 (OMP85) and APH_1359 (OMP1A) were also 
identified, but below a confident level.  The low level of OMP85 and OMP1A may simply 
be due to low levels of expression on the DC or due to inefficient extraction from the outer 
membrane.   
 Many of the proteins identified in this study are likely surface proteins as the 
results corroborate well with a previous biotinylation study of A. phagocytophilum (55).  
Although the above concerns will have to be addressed in future experiments, proteins 
identified from this study are currently being investigated by other members of the Carlyon 
lab.  The remainder of my dissertation was to focus on improving gradient purification as a 




A. phagocytophilum organisms at various stages of isolation examined by transmission 
electron microscopy.  Infected HL-60 cells were pelleted at 300 x g for 5 min, supernatant 
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was discarded and cell pellet was processed for TEM.  All samples were processed for 
TEM as previously described (173).   Ap RC and DC organisms (strain NCH-1) were 
recovered by syringe lysis as follows.  Heavily infected HL-60 cells with high bacterial 
loads were pelleted at 5,000 x g for 15 min at 4°C.  Cells were resuspended in a total of 9 
ml cold PBS with protease inhibitors (Roche; Indianapolis, IN, Cat. No. 11836153001) for 
every 250 x 106 cells.  Cells were lysed by 5 passages through a 27½ gauge needle (BD; 
Franklin Lakes, NJ, Cat. Nos. 305196, 305109) in a 50 ml tube.  The sample was 
distributed at a ratio of 100 x 106 cells in 45 ml PBS and centrifuged at 1,200 x g for 10 
minutes at 4°C to pellet large debris.  The supernatant was transferred to new tube and 
centrifuged at 4,500 x g for 15 minutes at 4°C to pellet Ap.  The bacterial pellet was 
processed for TEM.  DC organisms were recovered by sonication as follows.  Heavily 
infected HL-60 cells with high bacterial loads were pelleted at 5,000 x g for 15 min at 4°C.  
Cells were resuspended in 6 ml cold PBS with protease inhibitors for every 250 x 106 cells, 
and subjected to eight 8-sec bursts on ice interspersed with 8-sec rest periods using a 
Misonix S4000 ultrasonic processor (Farmingdale, NY) on an amplitude setting of 30.  The 
6 ml sample was brought up to 50 ml with PBS and centrifuged at 750 x g for 5 minutes at 
4°C to pellet large debris.  Supernatant was transferred to a new tube and centrifuged at 
1,000 x g for 10 minutes at 4°C to remove more debris.  Supernatant was transferred to a 
new tube and centrifuged at 4,500 x g for 10 minutes at 4°C to pellet Ap.  The bacterial 




Renografin purification of A. phagocytophilum DC organisms.  DC organisms were 
recovered by sonication and differential centrifugation as described above.  Ap pellet from 
500 x 106 cells was resuspended in 10 ml PBS with 0.2% glucose and treated with 50 
µg/ml of DNAse I (Roche, Cat. No. 10104159001) for 45 min at 37°C.  The sample was 
then layered on top of 30% - 42% discontinuous Renografin gradient, centrifuged, and 
organisms were recovered from 30% - 42 % interface as previously described (27).   
 
Biotinylation and purification of A. phagocytophilum DC surface proteins.  DC 
organisms recovered from the Renografin gradient were washed 2 times in 1 ml cold PBS 
at 5,000 x g for 5 minutes.  For biotinylation, Ap recovered from up to 1 x 109 cells was 
mixed in 1 ml PBS with 10 mM water soluble non-membrane permeable Sulfo-NHS-SS-
Biotin (Pierce; Waltham, MA, Cat. No. 21331) for 30 min at RT with rotation.  Organisms 
were pelleted at 5,000 x g for 5 min and the supernatant was discarded.  The Ap pellet was 
thoroughly resuspended in 1 ml of 50 mM Tris (pH 8.0) to quench the biotinylation 
reagent.  Ap pellet was washed two more times with 500 µl cold PBS.  The Ap pellet was 
lysed in 1 ml RIPA solution with protease inhibitors for 1 h on ice.  Every 20 min, the 
sample was subjected to sonication on an amplitude setting of 30 for four 8-sec bursts on 
ice interspersed with 8-sec rest periods.  Insoluble material was removed by centrifugation 
for 10 min at 10,000 x g at 4°C.  The supernatant was saved and transferred to ice.  
 The soluble fraction of the biotinylated sample was mixed with High Capacity 
NeutrAvidin Agarose Beads (Pierce, Cat. No. 29202) in 10 ml RIPA buffer with protease 
inhibitors O/N at 4°C with rotation.  The sample was centrifuged at 1,000 x g for 1 min, 
 
 115 
supernatant was removed (saved to verify purification of biotinylated proteins) and beads 
were resuspended in 10 ml cold PBS.  The sample was centrifuged again at 1,000 x g for 1 
min and the supernatant was discarded.  The beads were resuspended in 8 ml cold PBS.  
The sample was thoroughly mixed and 800 µl aliquots of slurry were removed from the 
tube and placed in one spin column (Pierce, Cat. No. 69725) a total of 10 times.  Columns 
were centrifuged at 1,000 x g for 1 min at 4°C.  The flow through was discarded.  Five 
hundred µl of cold PBS was added to the column, mixed and centrifuged again for a total 
of 3 washes.  A cap was placed on the bottom of spin column tube.  Five hundred µl of 
0.25% Na deoxycholate solution with 150 mM dithiothreitol (DTT) was added to the 
column.  The tube lid was closed and the sample was mixed for 2 h at RT with rotation.  
The cap from the bottom of the tube was removed and proteins were eluted into a new 
clean tube by spinning at 1,000 x g for 2 minutes.  All recovered/eluted samples were 
pooled into one tube and placed on ice.  The sample concentration was determined.  
Sample was stored at 4°C to prevent proteins from falling out of solution. 
 
MS identification of A. phagocytophilum DC surface proteins.  Two hundred µg 
purified biotinylated sample was concentrated with ultra-0.5ml centrifugal filter units 
(Fisher Scientific; Pittsburgh, PA, Cat. No. UFC501024).  Four hundred µl of sample was 
added as many times as needed to the centrifugal filter and centrifuged at 10,000 x g at RT 
to reduce the retentate to <50 µl.  Upon reduction, 400 µl of 50 mM ammonium 
bicarbonate (ABC) buffer with 0.05% Na deoxycholate was added and the sample was 
centrifuged at 10,000 x g at RT to reduce the retentate.  The wash was repeated a second 
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time and centrifuged to near dryness.  Filters were inverted and placed into new microfuge 
tubes, which were centrifuged at 3,000 x g at RT for 10 min to collect retentate.  The 
eluted volume was measured.  The eluted volume was subtracted from 25 µl.  A 90:10 (50 
mM ABC / Acetonitrile [ACN]) buffer of the subtracted volume was added to the top of 
the filter and incubated for 15 min.  The sample was eluted into the previously collected 
sample to yield a total volume of 25 µl.  One µl of fresh 500 mM DTT made in 50 mM 
ABC was added to sample and incubated for 30 min at 90°C.  The sample was then cooled 
to room temperature.  Trypsin (Promega; Madison, WI, Cat. No. V5280) (100 ng/µl) was 
added to a final 1:100 enzyme:protein ratio (20 µl trypsin for 200 µg of protein).  If a 
precipitate formed, then 0.5 µl ammonium hydroxide was added to the sample.  The 
sample was vortexed briefly and placed at 37°C O/N.  Samples were analyzed by MudPIT.  
Recovered peptide spectra data was search against the A. phagocytophilum (strain HZ) and 
human genome.  All identified A. phagocytophilum proteins were reported.   
 For protein identification to be considered an authentic result, we determined that 
the protein needed to have a minimal score of 300 with multiple recovered peptides.  This 
would allow for identified proteins to be considered as 99% authentic with only a 1% 
chance of error.  The score of the identified protein is the sum of several values, which 
includes the number of peptides recovered and percent coverage of proteins.  The number 
of peptides identified is derived from the total number of different ion measurements.  
These ion measurements depend on how a protein is digested and will include peptides that 
can contain multiple overlapping sequences from the same region of a protein.  The 
proteins in Table 5 are ranked by score, which is generally related to the abundance of a 
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given protein.  The more protein present in a sample, the more peptides should be 





CHAPTER 6:  Density-gradient Purification of the A. phagocytophilum 




 Our ability to confidently identify OMPs as adhesin(s) is dependent on isolation of 
the adherent A. phagocytophilum DC.  In the previous chapter, we were able to 
demonstrate that sonication combined with discontinuous density-gradient centrifugation 
was successful in recovering DC organisms, but we could not be confident that 
contamination from destroyed RC organisms did not occur.  The large abundance of host 
cell debris contamination generated from sonication was also an issue, as it could interfere 
with biotinylation and MS identification of A. phagocytophilum proteins.  Therefore, 
individual separation of undamaged RC and DC organisms will be required to ensure we 
identify and pursue only DC specific surface proteins.   
 Separation of the different biphasic developmental forms has been achieved with 
gradient-centrifugation for Chlamydia species and Coxiella burnetii (36, 156).  Isolation 
and characterization of pure developmental forms has allowed great insight into their 
structures and functions.  Because separation of RC and DC organisms has not been 
established for A. phagocytophilum, we set out to devise new methods to individually 




Isolation and purification of A. phagocytophilum RC organisms by dounce 
homogenization and OptiPrep density-gradient centrifugation. 
 In Chapter 5, we discovered that the destroyed RCs and host cell debris generated 
from sonication was a problem when selecting for DC organisms.  As an alternative, we 
chose to test dounce homogenization as a method for RC and DC isolation, as this is a 
gentler manner of cell lysis.  This method combined with density-gradient centrifugation 
has been successful in isolating mitochondria, lysosomes and other organelles from various 
cells and tissue (60-62), as well as for isolation of Neorickettsia risticii (104).  In an effort 
to lyse infected cells while keeping the A. phagocytophilum RC and DC undamaged, and 
reduce host cell debris contamination, we tested the efficiency of dounce homogenization.   
 Infected HL-60 cells were first placed in a hypo-osmotic solution to make them 
more susceptible to lysis from swelling.  Cells were lysed by dounce homogenization after 
which they were returned to an iso-osmotic state to prevent damage to the organisms and 
host cell vesicles.  Large cellular debris was removed by differential centrifugation, after 
which the recovered organisms were centrifuged through an OptiPrep discontinuous 
density-layered gradient.  We used OptiPrep in our gradients because the Renografin 
solution we used previously in Chapter 5 was no longer commercially available.  After 
centrifugation, we analyzed several interfaces of the gradient by TEM and found that the 
25% - 30% interface was the only layer that contained pure bacteria (Fig. 20).  The 25% - 












Figure 20.  A. phagocytophilum RC organisms recovered by dounce homogenization 
and density-gradient centrifugation.  Infected host cells were dounce homogenized and 
Ap organisms were purified by OptiPrep discontinuous density-gradient centrifugation.  
(A-C) TEM images of organisms recovered between the 25% - 30% OptiPrep interface.  




































None of the other analyzed layers contained any abundance or purity of DC organisms 
(data not shown).   
 
Attempts to isolate and purify A. phagocytophilum DC organisms by syringe lysis and 
OptiPrep density-gradient centrifugation.   
 Our TEM results revealed that dounce homogenization only recovered an RC-
enriched bacterial population.  Therefore, we had to try alternative approaches of lysing 
infected cells to maximize recovery of DC organisms.  We previously determined that 
syringe lysis is best suited for recovery of a mixture of both RC and DC organisms as seen 
in Figure 18B of Chapter 5.   
 To recover DC organisms, we repeatedly passed infected HL-60 cells through a 
18½ and 27½ gauge needles to destroy the host cell and release intact RC and DC A. 
phagocytophilum organisms.  Large cellular debris was removed by differential 
centrifugation, after which the recovered organisms were centrifuged through an OptiPrep 
discontinuous density-layered gradient.  After centrifugation, we analyzed several 
interfaces of the density-gradient by TEM and found that the 20% - 25% interface 
contained the greatest abundance of bacteria (Fig. 21).  The first time we tested this 
approach, we recovered a fairly pure population of DC organisms with little to no RCs 
(Fig. 21A).  However, repeated attempts to recover this DC-enriched population were 
unsuccessful, as only a mixed population of RC and DC organisms were recovered (Fig. 













Figure 21.  Attempts to purify A. phagocytophilum DC organisms by syringe lysis and 
density-gradient centrifugation.  Infected host cells were syringe lysed and organisms 
were purified by OptiPrep discontinuous density-gradient centrifugation.  (A-C) TEM 
images of organisms recovered between the 20% - 25% OptiPrep interface.  Results from 3 





































 These approaches were designed to isolate organisms from HL-60 cells while 
keeping the RC undamaged, as to prevent destroyed RC debris from comigrating and 
contaminating recovered DC organisms.  We observed that dounce homogenization and 
density-gradient purification was suited for recovery of intact RC organisms and greatly 
reduced cellular debris contamination compared to that observed when using sonication in 
Chapter 5 (Fig. 19).  Using this approach we obtained an RC-enriched bacterial population 
(Fig. 20), but unfortunately did not recover any significant population of DCs.  We 
determined that the lack of recovered DC organisms was a result of how the cells were 
lysed.  We know dounce homogenization releases A. phagocytophilum organisms from 
their inclusions, as indicated by the recovered RC-enriched population.  But we also know 
the host cells are gently lysed, which keeps many large membrane and cellular structures 
intact, including the host cell nucleus.  We think that as the A. phagocytophilum inclusions 
are broken open and the bacteria are released, the adherent DC organisms most likely binds 
to PSGL-1 on intact membrane cellular debris.  This large cellular debris is removed by 
differential centrifugation before it is ever added to the OptiPrep discontinuous density-
gradient, thus potentially preventing recovery of DC organisms.  Indeed, others have noted 
that intracellular organisms adhere persistently to host cell material (190, 198).  We also 
observed that the recovered RC organisms migrate at the 25% - 30% interface.  We 
ascertained that as the infected HL-60 cells are treated with the hypo-osmotic solution to 
aid in their lysis, the density of RC organisms' increases, which "shifts" the majority of the 
RC population to the 25% - 30% interface.  This in fact results in a more consistently 
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recovered RC-enriched population with minimal cellular debris contamination (Fig. 20).  
A few DC organisms can be observed within the RC-enriched population, but their 
presence is minimal.   
 In spite of the fact that purification of the A. phagocytophilum RC is of great 
benefit, our intent was to purify DC organisms.  Therefore, we next used syringe lysis to 
isolate organisms from infected cells, which we know recovers both intact RC and DC 
organisms, as previously demonstrated in Chapter 2 (Table 1) and Chapter 5 (Fig. 18B).  
Syringe lysis is more destructive to HL-60 cells and efficiently destroys host cell 
membrane structures, which ensures recovery of DC organisms.  Syringe lysis will result 
in more cellular debris contamination, but is a necessity to ensure DC recovery.  The first 
time we tested syringe lysis with OptiPrep discontinuous density-layered gradients, we 
recovered a DC-enriched bacterial population with little to no RC organisms at the 20% - 
25% interface (Fig. 21A).  Unfortunately, repeated attempts following the same protocol 
resulted in recovery of a mixed RC and DC bacterial population (Fig. 21B and C).  There 
could be several reasons for these discrepancies between experiments.  First, the 
population of DC organisms within the cultures during the first experiment may have 
simply been much greater.  Second, it could be a consequence of the biphasic 
developmental cycle exhibited by A. phagocytophilum.  The constant transitional 
continuum between RC and DC forms may prevent them from having a consistent density 
to allow for individual separation.  We have observed by TEM that DC organisms stopped 
at the 20%, 25%, and 30% layers of the OptiPrep density gradients (data not shown) 
thereby validating that the density of the organisms can vary.  Although the majority of the 
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DCs migrate to the 20% - 25% interface, the DC that migrates elsewhere is too few to 
pursue.  This variation in density contributes to an overall loss in recovery of DC 
organisms.  
 An assortment of attempts to remove the RC organisms from the DC were taken.  
These included, but were not limited to changing the speed of density-gradient 
centrifugation, as well as adding more or less density gradient layers, which were all 
unsuccessful.  We learned during dounce homogenization that the hypo-osmotic solution 
used to aid in cell lysis "shifted" the RCs to the 25% - 30% interface.  Since the DC was 
resistant to sonication, we thought they may also be resistant to osmotic changes as well.  
We tried treating the mixed bacterial population recovered by syringe lysis at the 20% - 
25% interface with the hypo-osmotic solution, then centrifuged the sample through a 
second OptiPrep discontinuous density-gradient to determine if we could "shift" the RC 
organisms at the 20% - 25% interface to the 25% - 30% interface, while leaving the DC at 
the 20% - 25% interface.  Although many RC organisms were "shifted" to the 25% - 30% 
interface, some DC organisms "shifted" as well.  This resulted in fewer DC at the 20% - 
25% interface, which was still was contaminated with a few RCs and a fair amount of 
cellular debris.  Overall, the approaches we took to remove RC organisms and cellular 
debris were unsuccessful in obtaining sufficient quantities of pure DC organisms.     
 
METHODS 
OptiPrep density-gradient purification of A. phagocytophilum RC organisms by 
dounce homogenization.  Infected HL-60 cells were pelleted at 500 x g for 10 min at 4°C.  
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The supernatant was discarded and cell pellets were resuspended at a ratio of 250 x 106 
cells in 50 ml cold PBS and centrifuged at 500 x g for 8 min at 4°C to wash the cells.  The 
supernatant was discarded and cells were resuspended at a ratio of 100 x 106 cells in 2 ml 
of hypo-osmotic solution (10 mM hepes, 10 mM potassium chloride [KCl], 1.5 mM 
magnesium chloride [MgCl2]) and placed on ice for 10 min.  Up to 7 ml at a time was 
placed in a dounce homogenizer (Kimble and Chase; Vineland, NJ, Part No. 885303-0007) 
and dounced with a tight fitting pestle (Kimble and Chase, Part No. 885302-0007) 20 
times.  Immediately after douncing, 1/3 of the total volume of a cold 1 M Sucrose solution 
(10 mM hepes, 10 mM KCl, 1.5 mM MgCl2, 1 M sucrose) was added to the dounced cells 
to return the solution to an iso-osmotic state of 0.25 M sucrose.  Dounced cells were 
resuspended at a ratio of 100 x 106 cells in 45 ml of cold 0.25 M sucrose solution (10 mM 
hepes, 10 mM KCl, 1.5 mM MgCl2, 0.25 M sucrose) and centrifuged at 1,000 x g for 10 
minutes at 4°C to pellet large cellular debris.  Supernatant was transferred to a new 50 ml 
tube and Ap organisms were pelleted at 4,500 x g for 15 minutes at 4°C.  The supernatant 
was discarded and the Ap pellet was resuspended at ratio of 500 x 106 cells in 6 ml cold 
0.25 M sucrose solution.  DNAse I (Roche; Indianapolis, IN, Cat. No. 10104159001) was 
added to a final concentration of 250 µg/ml and incubated at 37°C for 30 min.  The sample 
was added onto a discontinuous density-layered OptiPrep (Sigma-Aldrich; St. Louis, MO, 
Cat. No. 1556-250) gradient.  OptiPrep solution was diluted with the 0.25 M sucrose 
solution.  The OptiPrep discontinuous density-gradient was layered bottom to top with the 
following volumes and percentages of OptiPrep solutions; 6 ml of 30%, 5 ml of 25%, 5 ml 
of 20%, 3.5 ml of 17.5%, 3.5 ml of 15% and 3.5 ml of 12.5%.  Solutions were layered in 
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35 ml ultracentrifuge tubes (Beckman Coulter; Brea, CA, Part No. 344058).  Samples were 
centrifuged at 87,000 x g in an ultracentrifuge swinging bucket rotor for 1 hour and 15 
minutes at 4°C.  After centrifugation, the bands at the 25% - 30% interface were recovered 
and mixed with an equal volume of sucrose-phosphate-glutamate (SPG) buffer (0.25 M 
Sucrose, 7 mM KH2PO4, 3.7 mMK2HPO4, 5 mM L-glutamine  [pH 7]).  The sample was 
centrifuged at 15,000 x g for 10 min at 4°C.  The supernatant was discarded and Ap pellet 
was processed for TEM as previously described (173).    
 
OptiPrep density-gradient purification of A. phagocytophilum RC and DC organisms 
by syringe lysis.  Infected HL-60 cells were pelleted at 5,000 x g for 15 min at 4°C.  The 
supernatant was discarded and the cell pellet was resuspended in a total of 9 ml cold PBS 
with protease inhibitors (Roche; Indianapolis, IN, Cat. No. 11836153001) for every 250 x 
106 cells.  Cells were lysed by 5 passages through 18½ and 27½ gauge needles (BD; 
Franklin Lakes, NJ, Cat. Nos. 305196, 305109) in a 50 ml tube.  The sample was 
distributed at a ratio of 100 x 106 cells in 45 ml PBS, and centrifuged at 1,200 x g for 10 
minutes at 4°C to pellet large debris.  The supernatant was transferred to new tube and 
centrifuged at 4,500 x g for 15 minutes at 4°C to pellet Ap.  The supernatant was discarded 
and the Ap pellet was resuspended at ratio of 500 x 106 cells in 6 ml cold 0.25 M sucrose 
solution (10 mM hepes, 10 mM KCl, 1.5 mM MgCl2 and 0.25 M sucrose).  DNAse I 
(Roche, Cat. No. 10104159001) was added to a final concentration of 250 µg/ml and 
incubated at 37°C for 30 min.  The sample was processed as described above except that 





CHAPTER 7:  Characterization of Putative A. phagocytophilum      




 Even though the main focus of Chapters 5 and 6 were to improve upon recovery of 
DC organisms, several proteins identified in Chapter 5 were a priority to study while we 
continued to test new gradient procedures.  In Chapter 5, we used biotinylation to identify 
surface proteins of A. phagocytophilum DC organisms.  Using this approach, we identified 
known OMPs of A. phagocytophilum as well as OMPs identified for other Anaplasma 
species.  We rationalized that since we identified known OMPs, some of the newly 
identified proteins were most likely newly discovered OMPs.  Three hypothetical proteins 
recovered by biotinylation and identified by MS (Table 5) were of interest.  These proteins 
were APH_1235, APH_0248 and APH_0853.  These proteins have little to no homology 
with other bacterial species.  Since we presume that we are looking for unique proteins as 
adhesins to human PSGL-1, these proteins were of great interest to us and we set out to 







APH_1235 and APH_0248. 
 Two proteins of interest recovered by MS in significant enough quantities to 
designate them as authentic proteins were APH_1235 and APH_0248.  APH_1235 was the 
second most abundant protein identified by MS (Table 5) after the dominant surface 
protein of A. phagocytophilum, Msp2(P44).  Both APH_1235 and APH_0248 are small 
proteins.  APH_1235 is 14.7 kDa, while APH_0248 is 13.8 kDa.  We initiated our 
characterization of APH_1235 and APH_0248 by expressing them as GST fusion proteins 
in E. coli and using the recombinant proteins to raise mouse polyclonal antisera.  We next 
screened A. phagocytophilum synchronously infected HL-60 cells with anti-APH_1235 
and anti-APH_0248 in conjunction with an Ab against Msp2(P44), which is a 
constitutively expressed OMP.  The synchronously infected cells were screened at 18 h 
when the organisms should be a highly pure RC population, and 24 h, which is when DC 
organisms first begin to appear (Fig. 22).  At 18 h and 24 h, 0% and 21% of inclusions, 
respectively, expressed APH_1235.  At 18 h and 24 h, 97% and 100% of inclusions, 
respectively, expressed APH_0248.  This suggests that APH_1235 is a DC-specific 
protein, and APH_0248 is expressed on RC and DC organisms.   
 
APH_0853 
 One very unique protein we identified, although it is just below the threshold of 
authenticity as determined by MS, was hypothetical protein APH_0853.  When searched 
against The National Center for Biotechnology Information (NCBI) protein database using 
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the basic local alignment search tool (BLAST), this 10.8 kDa protein did not have 
homology to any single protein (Fig. 23A).  Because of the uniqueness of APH_0853, we 
decided to compare the DNA sequence of our A. phagocytophilum strain to  A. 
phagocytophilum-Variant 1 (ApVar-1).  ApVar-1 is a strain of A. phagocytophilum that 
does not infect mice or human cell lines (114, 115).  The reservoir in nature is believed to 
be White-tailed deer, although goats are also susceptible to infection (113).  The ApVar-1 
strain is cultivated in tick cell lines for laboratory studies (112).   
 Although this strain cannot infect human cell lines, we do not yet know if it can 
bind human PSGL-1.  Nonetheless, we compared the sizes of PCR products from 5 full-
length putative OMP genes identified by biotinylation (Table 5).  The only gene that had 
an obvious size difference was aph_0853 (Fig 23B).  We next sequenced aph_0853 from 
ApVar-1 (genome sequence not yet available) and compared its DNA sequence and 
translated protein sequence to those of the NCH-1 strain, which is infectious for humans.  
We found that the aph_0853 gene of ApVar-1 had several point mutations as well as large 
and small insertions (Fig 24A).  If this protein were expressed, it would be nonfunctional 
as the mutations in the DNA sequence produce a premature stop codon at amino acid 17, 
which would result in a 1.9 kDa protein.  This data demonstrates that APH_0853 is 
expressed in an A. phagocytophilum strain that infects humans, but is severely truncated in 












Figure 22.  APH_1235 and APH_0248 expression during intracellular infection.  HL-
60 cells were synchronously infected with A. phagocytophilum.  At 18 h (A-C and G-I) 
and 24 h (D-F and J-L) post-infection, cells were fixed with methanol and viewed by 
immunofluorescence microscopy for immunoreactivity with antibodies against Msp2(P44); 
used to denote bacteria in A, D, G and J), anti-APH_1235 (B and E) and anti-APH_0248 
(H and K).  Merged fluorescent images with DAPI (stains host cell nuclei) are presented in 












































Figure 23.  APH_0853 BLAST search and PCR results.  (A) Result of APH_0853 
protein BLAST search of the NCBI database.  (B) PCR products of full length genes were 















































Figure 24.  DNA and protein sequences of APH_0853.  (A) Alignment of DNA 
sequences of full length aph_0853 of the human infectious A. phagocytophilum (Ap) strain 
and the non human strain (ApVar-1).  (B) Alignment of amino acid sequence of the two 
strains.  Red asterisks indicate homology and blue bold text indicate differences between 















                     10        20        30        40        50        60  
                      |         |         |         |         |         |  
Ap           ATGTTGATAGATGATCATGCAGCTGATTTTTTTT-GCAAGATTATCTGTACGTTTAAGGT  
ApVar-1      ATGTTGATAGATGATCATGCAGCTGATTTTTTTTTGCAAGATTATCTGTA-GTTTAAGGT  
             ********************************** *************** *********  
                     70        80        90       100       110       120  
                      |         |         |         |         |         |  
Ap           AGCAAAGAGATTTAGTAGTGTAGCAGAATATGT---------------------------  
ApVar-1      AGCAAAGAGATTTAATAGTGCAGCAGAATATGTGCTGATATCACTCTGTTACGGACAACT  
             ************** ***** ************                            
   
                    130       140       150       160       170       180  
                      |         |         |         |         |         |  
Ap           ------------------------CTTGCTGCAGATAAACACAAATCTTTACCCAGGAGC  
ApVar-1      AACTCAGTACATAAGAGTGCTATGCTCGCTGCAGATAAACACAAATCTTTACCCAGGAGC  
                                     ** *********************************  
   
                    190       200       210       220       230       240  
                      |         |         |         |         |         |  
Ap           GCGCTCCTCTAGGAAAGGCATGGCTCTTTCTGAGATCAACCGCATGTCCACGCAATTTTA  
ApVar-1      GCGCTCCTCTAGGAAAGGCATGGCTCTTTCTGAGATCAACCGCATGTCCATGCAATTTTA  
             ************************************************** *********  
   
                    250       260       270       280       290       300  
                      |         |         |         |         |         |  
Ap           TGCTGTTCAGCCAACATCC---CGAGATTGTGGAATAAAAAAATGCCAACACAGTAGTAG  
ApVar-1      TGCTGTT-AGCCAATATTTATATAAGACTGCGGAATAAAAAA-TGCCAATACAGTAGCAA  
             ******* ****** **       *** ** *********** ****** ******* *  
   
                    310       320       330       340  
                      |         |         |         |  
Ap           TTTTGTTTTTTATGATTTGGCACGTATGTCCGGTCCTGGTGCAACCTGA  
ApVar-1      TTTTGTTTTTTATGATTTGATACGTATGTCCGGTCCTGGTGCAACCTGA  







Ap           MLIDDHAADFFCKIICTFKVAKRFSSVAEYVLLQINTNLYPGARSSRKGMALSEINRMST  
ApVar-1      MLIDDHAADFFLQDYL(STOP)-------------------------------------- 
   ***********           
 
Ap         QFYAVQPTSRDCGIKKCQHSSSFVFYDLARMSGPGAT(Stop) 





 Our data demonstrates that we have identified APH_1235 as the first DC-specific 
protein of A. phagocytophilum.  Although further characterization will be required to prove 
that the protein is in fact an OMP, its identification as the second most abundant protein 
after Msp2(P44) in our biotinylation study (Table 5) of DC organisms strongly suggests 
that APH_1235 is a DC-specific protein.  This is further reinforced by the lack of detection 
of APH_1235 expression at 18 h (Fig. 22B), a time point at which the A. phagocytophilum 
population should exclusively consist of RC organisms.  However, at 24 h, a time point 
concurrent with the appearance of DC organisms, APH_1235 expression is detectable (Fig. 
22E).  When APH_0248 expression was monitored, it was detected at both 18 and 24 h, 
suggesting that this protein is expressed on both RC and DC organisms.  Even though MS 
identified APH_0248 from a DC-enriched population, it is not surprising that some 
proteins that are on DC organisms will also be present on RCs.  
 Attempts to raise antiserum to APH_0853 were unsuccessful and are currently 
being retried.  Although we have not yet determined when this protein is expressed during 
development, we have determined that it is exclusively unique to A. phagocytophilum.  A 
BLAST search demonstrated that APH_0853 does not have homology to a single other 
protein in the NCBI database (Fig. 23A).  Also, APH_0853 is non-functional in the non-
human strain ApVar-1 due to a premature stop codon.  APH_0853 is unique to the human 
infectious strain of A. phagocytophilum and its recovery from DC-enriched organisms 
makes this protein a priority to pursue as a potential DC-specific OMP that could function 
as an adhesin.    
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 The manner by which these proteins are associated with the A. phagocytophilum 
outer membrane is unknown.  None of these proteins were predicted as OMPs by any of 
the programs used in Chapter 3 to analyze the A. phagocytophilum genome.  The program 
CELLO, which predicted 130 potential OMPs (Table 3), classifies these 3 small proteins 
as cytoplasmic (data not shown).  None of the proteins contain signal sequences that would 
conceivably direct them to the outer membrane when analyzed by the signalP program.  
Computer analyses to look for potential transmembrane helices were inconsistent, as 
programs predicted 0, 1 or 2 helices for each protein (data not shown).  Lastly, since we 
demonstrate that APH_1235 and APH_0248 are expressed during infection, these proteins 
should no longer be classified as hypothetical proteins but instead be designated as 




Recombinant protein expression and generation of antisera.  Full length proteins of 
interest were expressed as GST fusion proteins according to manufacturer's instructions 
using the pENTR directional TOPO cloning kits pENTR/TEV/D-TOPO (Invitrogen; 
Carlsbad, CA, Cat. No. K2525-20) and E. coli expression system with gateway technology 
pDEST-15 (Invitrogen, Cat. No. 11802-014).  Insoluble proteins were solubilized in 
Sarkosyl as previously described (168).  SnakeSkin dialysis tubing (Pierce; Waltham, MA) 
was used to remove detergents and place proteins into a PBS solution.  Purified proteins 
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were submitted for production of mouse polyclonal antiserum.  Anti-GST-APH_0248 and 
Anti-GST-APH_1235 is referred to as anti-APH_0248 and anti-APH_1235, respectively. 
 
APH_1235 and APH_0248 infection time course and immunofluorescence 
microscopy.  A. phagocytophilum organisms were recovered from 10 times the number of 
infected HL-60 cells by syringe lysis as described (27) and added to naïve HL-60 cells to 
initiate a synchronous infection.  For bacterial adherence, A. phagocytophilum organisms 
were incubated at a ratio of 2.0x106 HL-60 cells in 1 ml of IMDM-10 (Invitrogen) for 1 
hour.  Host cells were pelleted at 300 x g for 5 min, washed twice with PBS to remove 
unbound bacteria, and incubated in IMDM-10 at 37°C in 5% CO2.  At 18 h and 24 h, 
35,000 cells per sample were removed and centrifuged onto glass slides using a Shandon 
Cytospin 4 cytocentrifuge (Thermo Scientific, Waltham, MA) as described previously 
(27), followed by fixation in methanol for 4 min and stored at -20°C. 
 For immunofluorescence microscopy slides were blocked with 5% BSA/PBS for 1 
hour.  Mouse anti-APH_1235 and anti-APH_0248 sera were added for 45 min at dilutions 
of 1:100 and 1:200, respectively, in 1% BSA/PBS.  The antisera were removed by 
aspiration and then rabbit anti-MPB-Msp2(P44) was added for 30 min at a 1:500 dilution 
in 1% BSA/PBS.  The slides were washed 3 times in TBS-t (0.5%) for 2 min each, 
followed by Alexa Fluor 594-conjugated goat anti-mouse IgG (Invitrogen) for 30 min at a 
1:1,000 dilution in 1% BSA/PBS.  The antisera were removed by aspiration and then 
Alexa Fluor 488-conjugated goat anti-rabbit IgG (Invitrogen) was added for 30 min at a 
1:500 dilution in 1% BSA/PBS.  The slides were washed 3 times in TBS-t (0.5%) for 2 
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min each, followed by mounting with Prolong Antifade Gold with 4',6-diamidino-2-
phenylindole (DAPI) (Invitrogen).  The cells were examined for inclusions using an 
Olympus BX51 microscope.  A minimum of 100 inclusions was scored per time point. 
 
DNA sequencing and alignments.  Primers were designed to amplify 5 full-length genes 
of interest.  The primers were as follows: APH_0248 (F) 5'-CACCATGATACCATTAGC 
TCCTTGGAAGAGC-3' and (R) 5'-TTAGCTTTCTTTAGGAGTATTGGCACCGTAA-3', 
APH_0625 (F) 5'-CACCATGACCGGAGTGTACTATTCCATTGGTG-3' and (R) 5'-
CTAGCCTGTTATTAGACCAAAGTCTCTATAAAACTTTTCTGC-3', APH_0853 (F) 
5'-CACCATGTTGATAGATGATCATGCAGCTGATTTTT-3' and (R) 5'-TCAGGTTG 
CACCAGGACC-3', APH_1049 (F) 5'-CACCTATGTTAACAAAAAGGGAATATTCAG 
TGACATGGG-3' and (R) CTAAGAATTAAGGTACTTATTAACGAAATCAAAAAGT 
CTACCTACT-3', and APH_1235 (F) 5'-CACCATGAAAGGAAAGTCAGATTCTGAAA 
TACGTACG-3' and (R) 5'-CTAACCTTGGGTCGATGCCACAATTTTC-3'.  The 
underlined nucleotides correspond to a Gateway-compatible sequence.  Genes were 
amplified from the NCH-1 strain, which is infectious for humans, and the non-human 
strain ApVar-1.  PCR size products were compared by agarose gel electrophoresis.  PCR 
products for aph_0853 from ApVar-1 were cloned into the pENTR/TEV/D-TOPO cloning 
vector (Invitrogen, Cat. No. K2525-20).  The insert sequences were sequenced and verified 
as correct.   
 Sequence alignments of APH_0853 were aligned using the http://npsa-
pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page=/NPSA/npsa_clustalwan.html program for 
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protein and http://npsa-pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page=/NPSA/npsa_clustal 







CHAPTER 8:  Conclusions 
 
 
 The results of this dissertation highlight the unusual and complex features of A. 
phagocytophilum.  We characterized many important features about adhesion to PSGL-1 
and potentially identified the first DC-specific A. phagocytophilum OMP.  Previous work 
largely suggests that the A. phagocytophilum adhesins are surface exposed proteins.  Our 
work was able to further demonstrate that the A. phagocytophilum DC is environmentally 
resistant, and responsible for binding human PSGL-1.  We have established the DC's role 
as the adherent/infectious form of A. phagocytophilum, whereas the RC is fragile, does not 
bind human PSGL-1 and is the replicative form.  This is in agreement with analogous 
forms of other obligate intracellular bacteria that undergo biphasic development.  
 Our attempts to capture adhesins by receptor crosslinking and affinity purification 
met with little success.  We did learn that A. phagocytophilum must adhere to immobilized 
PSGL-1.  The negative results from crosslinking, immunoprecipitation, and data from 
other lab members demonstrate that adherence to PSGL-1 is more complex than first 
realized.  All of the approaches we tested have successfully identified adhesins of other 
pathogens.  The inability to recover A. phagocytophilum adhesin(s) either suggests that 
there is a very weak affinity between the adhesin and receptor or that a multifaceted 
protein complex is required for adhesion to bind PSGL-1, thus preventing its direct 
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recovery by the methods employed in this study.  Although we used computer predictions 
to identify outer membrane proteins in this study, they mainly serve as a good reference for 
comparison to experimental data.  It is likely that some of these predictions are accurate, 
but the focus of my dissertation was to specifically identify proteins by experimental 
means.  This would allow time to be spent focusing on proteins that were actually proven 
to be OMPs.   
 Our first attempt to identify OMPs by sonication, Renografin density-gradient 
purification and biotinylation was successful.  We identified 3 known surface proteins as 
well as those previously identified by biotinylation.  It is likely that many of the proteins 
we identified in our biotinylation approach are DC-specific.  However, some of the 
identified proteins may have come from RC organisms.  Consequently, we had to devise 
and test new gradient procedures using new and untested approaches. 
 Our expectation of using discontinuous density-gradient centrifugation to purify 
DC organisms was partially successful.  The best results we obtained thus far are recovery 
of mixed populations of RC and DC organisms from syringe lysis.  These organisms are 
contaminated with less cellular debris after gradient-centrifugation than if they were 
isolated by syringe lysis alone.  Although not ideal, they can still serve as a template in 
biotinylation studies to identify surface proteins.  This would identify surface proteins on 
both developmental forms, but will still provide a list of proteins on which to focus our 
attention.  Although we may try to improve these gradient procedures, the continual 
transition between RC and DC organisms may prevent us from ever recovering a pure DC 




 If we cannot isolate pure DC organisms by discontinuous density-gradient 
centrifugation, then there is an alternative approach that we will try.  We can use the 
adherent property of the DC as a means to isolate it from RC organisms and cellular debris.  
We know that A. phagocytophilum organisms will bind to rhPSGL-1 immobilized to 
ELISA plates.  We could isolate organisms by syringe lysis, and incubate them over a plate 
coated with rhPSGL-1.  Only adherent DC organisms will bind to rhPSGL-1, thereby 
allowing for RC organisms and cellular debris to be washed away.  DC organisms can then 
be scrapped off the plate and pelleted.  Although theoretically possible, the yield of 
recovered DC organisms may be minimal and, if so, would require large-scale application.      
 Identification of putative OMPs in Chapter 5 and characterization of APH_1235 
and APH_0248 in Chapter 7 demonstrates the strength of biotinylation to identify new 
proteins.  If additional work confirms APH_1235 and APH_0248 as OMPs, it will 
reinforce the argument that some OMPs of A. phagocytophilum will have to be discovered 
by experimental methods and cannot be predicted.  As mentioned above, use of mixed RC 
and DC organisms recovered from OptiPrep discontinuous density-gradient centrifugation 
still serves as a valuable resource for biotinylation studies to identify OMPs.  We do not 
know how many proteins are differently expressed between the RC and DC.  All we know 
for certain is that the DC upregulates or optimally modifies proteins allowing them to 
functions as adhesins.  If a list of OMPs is generated from both RC and DC organisms, 
there are ways that we could narrow down on which proteins to focus our attention.  Once 
antiserum is generated against a protein of interest, we can screen a lysate of the RC-
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enriched bacteria and compare it to a lysate of both RC and DC organisms.  Presumably, 
any surface protein that functions as an adhesin should be detected in the lysate of mixed 
organisms but not in the RC-enriched lysate.  A similar approach would be to monitor 
genes of interest by real-time PCR over the course of a synchronous infection.  Genes 
expressed late in development, concurrent with the appearance of DC organisms would be 
a priority to study.   
 Another potential approach that we could try is to reduce the list of OMPs by 
comparing the DNA sequence of our NCH-1 and other strains that infect human cells to 
that of ApVar-1.   If and only if the ApVar-1 does not bind human PSGL-1, it would imply 
that one or more proteins are missing or mutated on the ApVar-1 surface, thereby resulting 
in the loss of adhesion to human cells.  A direct comparison between ApVar-1 and our 
human strains may allow for identification of putative adhesins.  A prime example is 
protein APH_0853.     
 Purification of the A. phagocytophilum RC will be invaluable for future 
experiments.  Even though our focus was to identify OMPs using these purified organisms, 
we have the added bonus of using them to obtain the RC proteome.  This will provide great 
knowledge into which proteins are involved in replication, metabolism, and potentially 
identify virulence proteins required for intracellular survival.  If DC organisms can be 
purified in the future, characterization of their proteome will potentially identify 
prepackaged effector proteins and other proteins that are crucial during the early stages of 
binding and infection.  Purification of the A. phagocytophilum RC is a vital step forward in 
this direction.  Characterization of the two developmental forms will allow for 
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identification of RC and DC specific markers.  This was indeed the case for the purified 
developmental forms of Coxiella burnetii (36).  Two highly upregulated proteins were 
found to be associated with the infectious SCV (71, 72), and have since been identified as 
DNA-binding proteins that are only present in the compacted chromatin of the infectious 
SCV.  Presumably A. phagocytophilum has proteins of similar function.  We have since 
tested improved urea-based lysis buffers, which greatly enhances solubilization of purified 
samples compared to RIPA.  Complete solubilization of samples will be critical to recover 
all the proteins associated with each developmental form.  APH_1235 is likely an OMP; 
and preliminary data suggests that it is DC specific.  If APH_1235 is confirmed as DC-
specific, it will serve as the first maker to distinguish between the two A. phagocytophilum 
developmental forms.  This will allow us to rapidly distinguish between forms, thus 
eliminating the need to confirm experimental results by TEM.         
 A long term goal of the Carlyon lab is to identify OMPs as adhesins to the 
confirmed human receptor PSGL-1.  Though it may take some time to identify and 
specifically prove an OMP as an adhesin to human PSGL-1, any OMPs we identify in the 
process will be of great value.  At this time very little is known about how A. 
phagocytophilum is transmitted from a tick and infects a host.  I believe that DC organisms 
are transferred in some fashion from the tick to the host during a blood meal.  Ticks feed 
on a variety of mammals and I do not believe A. phagocytophilum has the ability to know 
the host it will next infect.  This implies the A. phagocytophilum DC must have the 
adhesins on its surface ready to bind many diverse receptors.  As mentioned earlier, we 
have observed by TEM the infectious DC form of A. phagocytophilum isolated from HL-
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60 cells binding to mouse mast cells (unpublished data).   Because the DC is presumably 
metabolically inactive, it would not have the ability to upregulate proteins specific to the 
host into which it was just transmitted.  This strongly implicates that the adhesin(s) for 
multiple cells types are likely expressed on the DC surface.   
 I believe that A. phagocytophilum has a select number of adhesins that 
cooperatively act in various combinations that allow the organisms to bind to a variety of 
different receptors, resulting in infection of various cell types within mammalian and tick 
hosts.  Therefore, if an identified surface protein does not function as an adhesin to human 
PSGL-1, it may be equally important in infection of another mammal.  Nonetheless, 
identification of other proteins as adhesins of human PSGL-1 will have great value and 
application to other organisms.  Fucosylation of human, mouse and tick cells lines is 
critical for A. phagocytophilum infection (29, 137, 194).  If the bacterial adhesin 
responsible for binding fucose on human PSGL-1 is identified, it will have broad 
implications for protection against A. phagocytophilum infection of more than humans 
alone.  Further identification and characterization of A. phagocytophilum surface exposed 
proteins will greatly enhance our understanding of mammalian infection by this potentially 
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